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Abstract 
Background 
Neuropeptides with an Amino Terminal Cu(II), Ni(II) Binding (ATCUN) motif (H2N-xxH) 
bind Cu(II)/Ni(II) ions. Here we report the novel discovery of a neuropeptide precursor that 
gives rise to a “cocktail” of peptides that bind Cu(II)/Ni(II) and form ternary complexes – the 
L-type SALMFamide precursor in the starfish Asterias rubens. 
Methods 
Echinoderm transcriptome sequence data were analysed to identify transcripts encoding 
precursors of SALMFamide-type neuropeptides. The sequence of the L-type SALMFamide 
precursor in the starfish Asterias rubens was confirmed by cDNA sequencing and peptides 
derived from this precursor (e.g. AYHSALPF-NH2, GYHSGLPF-NH2 and LHSALPF-NH2) 
were synthesised. The ability of these peptides to bind metals was investigated using UV/Vis, 
NMR, circular dichroism and EPR spectroscopy. 
Results 
AYHSALPF-NH2 and GYHSGLPF-NH2 bind Cu(II) and Ni(II) and generate metal-linked 
dimers to form ternary complexes with LHSALPF-NH2. Investigation of the evolutionary 
history of the histidine residue that confers these properties revealed that it can be traced to 
the common ancestor of echinoderms, which is estimated to have lived ~500 million years 
ago. However, L-type precursors comprising multiple SALMFamides with the histidine 
residue forming an ATCUN motif appears to be a feature that has evolved uniquely in 
starfish (Asteroidea). 
General Significance 
The discovery of a SALMFamide-type neuropeptide precursor protein that gives rise to a 
“cocktail” of peptides that bind metal ions and generate metal-linked dimers provides a new 
insight on ATCUN motif-containing neuropeptides. This property of L-type SALMFamides 
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in the Asteroidea may be associated with a role in regulation of the unusual extra-oral feeding 
behavior of starfish.  
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1.0 Introduction 
Neuropeptides are neuronal intercellular signalling molecules that act as 
neurotransmitters, neuromodulators or neurohormones and regulate many physiological 
processes and behaviours in humans and other animals [1]. They are derived from larger 
precursor proteins and are subject to post-translational modifications that are important for 
function; for example, in many neuropeptides a C-terminal glycine residue is converted to an 
amide group. Furthermore, in some neuropeptides the presence of a histidine residue can 
confer the ability to bind metal ions. In particular, the presence of an Amino Terminal Cu(II), 
Ni(II) Binding (ATCUN) motif, where a histidine residue is specifically located in the third 
position from the N-terminus (i.e. H2N-xxH, where x is variable), has been found to confer 
high affinity binding of Cu(II) and Ni(II). The ATCUN motif was originally characterized in 
albumins but subsequently it has been demonstrated that other peptides/proteins with an 
ATCUN motif also bind Cu(II) and/or Ni(II) ions [2, 3]. In 1995 Harford and Sarkar 
demonstrated that the mammalian neuropeptide neuromedin C, which has the N-terminal 
sequence Gly-Asn-His, binds both Cu(II) and Ni(II) specifically. Furthermore, the authors 
speculated that this property of neuromedin C may have relevance to neurological deficits 
associated with copper metabolism disorders, such as Menkes disease and Wilson disease [4]. 
More recently, Russino et al. reported that the mammalian tachykinin-type peptide 
neurokinin B, which contains an ATCUN motif, binds Cu(II) ions in an unusual 
[CuII(NKB)2] complex [5].  Furthermore, although Cu(II) binding substantially alters the 
structure of neurokinin B, the ability of [CuII(NKB)2] to activate the NKB receptor was not 
impeded. It was speculated that NKB may have a role in protecting cells from the effects of 
neuronally released copper. Several other members of the tachykinin peptide family have also 
been shown to coordinate copper ions, yet the physiological consequences remain to be 
determined [6, 7].   
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Here we report the novel discovery of a neuropeptide precursor protein that gives rise 
to a “cocktail” of neuropeptides that bind Cu(II) – the starfish L-type SALMFamide 
precursor. SALMFamide neuropeptides occur in species belonging to the phylum 
Echinodermata, which includes starfish, brittle stars, sea urchins, sea cucumbers and feather 
stars [8]. The first members of this neuropeptide family to be identified, S1 and S2, were both 
isolated from the starfish species Asterias rubens and Asterias forbesi. S1 is an octapeptide 
with the amino acid sequence GFNSALMF-NH2 and S2 is a dodecapeptide with the amino 
acid sequence SGPYSFNSGLTF-NH2 [9, 10]. Subsequently, SALMFamides were identified 
in other echinoderms, including GFSKLYF-NH2 and SGYSVLYF-NH2 from the sea 
cucumber Holothuria glaberrima and GYSPFMF-NH2 and FKSPFMF-NH2 from the sea 
cucumber Apostichopus japonicus [11]. Identification of these holothurian neuropeptides 
revealed the existence of two types of SALMFamides. Firstly, L-type SALMFamides that 
have the C-terminal motif SxLxF-NH2 (e.g. S1, S2, GFSKLYF-NH2 and SGYSVLYF-NH2) 
and secondly, F-type SALMFamides that have the C-terminal motif SxFxF-NH2 
(GYSPFMF-NH2 and FKSPFMF-NH2). 
 Investigation of the bioactivity of SALMFamides in echinoderms has revealed that 
both L-type and F-type SALMFamides act as muscle relaxants [12]. For example, S1 and S2 
both cause dose-dependent relaxation of apical muscle, tube foot and cardiac stomach 
preparations from the starfish A. rubens [13, 14]. Furthermore, S2 exhibits higher 
potency/efficacy than S1, which provided a rationale for investigation of a structural basis for 
this difference in bioactivity. By testing chimeric analogs of S1 and S2, it was found that it is 
the C-terminal region of the peptides that is the primary determinant of their differing 
potency/efficacy [15, 16]. However, the N-terminal tetrapeptide (SGPY) of S2 contributes to 
its bioactivity and confers on S2 the property to self-associate and form highly structured 
multimers at high concentrations [15]. Interestingly, addition of the SGPY tetrapeptide to the 
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N-terminus of S1 confers structure that is not observed with the S1 peptide, but without 
enhancing bioactivity. Thus, the differing bioactivity of S1 and S2 is determined by a 
complex interplay of sequence and conformation.  
 Advances in genome/transcriptome sequencing have enabled determination of the 
sequences of SALMFamide neuropeptide precursor proteins. For example, sequencing of the 
genome and transcriptome of the starfish Patiria miniata revealed: 1) an “L-type” precursor 
comprising S1 and six other L-type SALMFamides and 2) an “F-type” precursor comprising 
eight F-type or F-type-like SALMFamides and an S2-like peptide (L-type). Furthermore, 
comparative analysis of sequence data from a variety of echinoderm species has enabled 
investigation of the evolution of SALMFamide precursors [17, 18]. The phylum 
Echinodermata comprises five extant classes, Asteroidea (starfish), Ophiuroidea (brittle 
stars), Echinoidea (sea urchins, sand dollars), Holothuroidea (sea cucumbers) and Crinoidea 
(feather stars and sea lilies), and the phylogenetic relationships of these classes have been 
determined. Thus, the Asteroidea and Ophiuroidea are sister classes (the Asterozoa) and the 
Echinoidea and Holothuroidea are sister classes (the Echinozoa), with the Crinoidea basal to 
the Asterozoa and Echinozoa [19-26]. This phylogeny has provided a framework to 
reconstruct the evolution of SALMFamide precursors in the phylum Echinodermata. In 
crinoid species only a single SALMFamide precursor has been identified, whereas asterozoan 
and echinozoan species have both an L-type and an F-type precursor. It has therefore been 
postulated that the L-type and F-type precursors found in asterozoans and echinozoans may 
have arisen by duplication of a common ancestral-type precursor similar to that found in 
extant crinoids [17].       
 Here we have obtained additional sequences of SALMFamide precursors in 
echinoderm species representing the five extant classes. Comparative analysis of the 
sequences of echinoderm SALMFamide precursors revealed that several neuropeptides 
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derived from L-type SALMFamide precursors in starfish have an ATCUN motif. For 
example AYHSALPF-NH2, a neuropeptide that has been identified previously in the starfish 
species Marthasterias glacialis [27]. In addition, one of the peptides derived from L-type 
SALMFamide precursors in starfish (e.g. LHSALPF-NH2) has a histidine in the same 
position as the tripeptide Gly-His-Lys (GHK), a well-studied naturally occurring human 
copper-binding growth factor [28]. We show here that L-type SALMFamides in the starfish 
A. rubens that have an ATCUN motif are able to bind Cu(II) and Ni(II). Furthermore, Cu(II) 
binding to these peptides facilitates formation of ternary complexes with LHSALPF-NH2. 
The evolutionary and functional significance of these properties of neuropeptides derived 
from the L-type SALMFamide precursor in starfish is discussed. 
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2.0 Materials and Methods 
2.1 Transcriptome sequencing 
 The sequences of SALMFamide precursors have been determined in species 
representing all five echinoderm classes, as reported previously [17, 18]. Here we have 
obtained additional transcriptome sequence data from other species belonging to each of the 
five echinoderm classes: the starfishes Asterias rubens and Remaster gourdoni (class 
Asteroidea), the brittle stars Ophioderma brevispinum and Astrophyton muricatum (class 
Ophiuroidea), the sea urchins Arbacia punctulata and Eucidaris tribuloides (class 
Echinoidea), the sea cucumbers Psolus spp, Stichopus chloronatus and Pannychia moseleyi 
(class Holothuroidea) and the feather stars Isometra vivipara and Oligometra serripinna 
(class Crinoidea).  
Asterias rubens radial nerve cord transcriptome sequence data were obtained as 
reported previously [29]. For the other echinoderm species, RNA was extracted from tube 
feet (Remaster gourdoni), arms (Ophioderma brevispinum, Astrophyton muricatum), body 
wall (Arbacia punctulata, Eucidaris tribuloides, Psolus spp, Stichopus chloronatus, 
Pannychia moseleyi) or pinnules (Isometra vivipara, Oligometra serripinna) and then 
subjected to RNA-Seq sequencing on an Illumina Hiseq 2000 platform (100 base pairs, 
paired end). Reads for each of the samples were filtered by quality score (cutoff threshold > 
Q20) using fastxtrimmer and Illumina adapters were removed using fastxclipper, which are 
both components of the fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). De novo 
assembly of contigs was then performed using Trinity on a high memory computer cluster 
using 500 GB of RAM and 24 CPUs [30].   
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2.2 Cloning and sequencing of the L-type SALMFa precursor cDNA from A. rubens 
SALMFamides derived from the A. rubens L-type SALMFamide precursor were 
selected for the metal-binding studies described below. To facilitate this it was first necessary 
to confirm, by cDNA cloning and sequencing, the sequence of the precursor predicted from 
Illumina transcriptome sequencing. Total RNA from radial nerve cords of A. rubens was 
isolated using the Total RNA Isolation System (Promega) and used for cDNA synthesis using 
the Quantitect Reverse Transcription Kit (QIAgen). The full-length cDNA of the A. rubens 
L-type SALMFa precursor, including 5′ and 3′ untranslated regions (UTR), was amplified by 
PCR using Phusion high-fidelity PCR master mix (NEB) and the oligos 5′-
TAGCTACTTGACACA-3′ and 5′-ATATGACTAGTTGAGAGAGG-3′, which were 
designed using Primer3 software (http://bioinfo.ut.ee/primer3-0.4.0/). The PCR product was 
gel-extracted and purified using a QIAquick gel extraction kit (QIAgen) before being blunt-
end cloned into a pBluescript SKII (+) vector (Agilent Technologies) cut with a EcoRV-HF 
restriction endonuclease (NEB). The clone was then sequenced (Eurofins Genomics) from the 
T7 and pCR3.1-BGH-rev sequencing primer sites. 
 
2.3 Neuropeptide synthesis and metal titrations 
The A. rubens L-type SALMFamides AYHSALPF-NH2, GYHSGLPF-NH2 and 
LHSALPF-NH2 were synthesised by Synpeptide (Shanghai, China) and were >95% pure as 
determined by mass spectrometry and NMR. The lyophilized peptides were weighed and 
dissolved in the required buffer (10 mM nEM unless otherwise stated) on the day of use. The 
peptide concentration was estimated using the extinction coefficient of the single tyrosine 
amino acid (H280nm = 1280 M-1cm-1) or from the measured mass taking into consideration the 
presence of ~30% water. Stock (0.5 M) solutions of copper and nickel were prepared as 
CuCl2·2H2O and NiCl2·2H2O in water and diluted to working solutions on the day of use. 
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Metal addition during titrations was achieved using a 10 PL Hamilton gastight syringe. The 
spectrum of metal-free peptide was subtracted from the spectrum after each metal addition 
and dilution effects were taken into account during processing of the spectra.  
 
2.4 Electronic Spectroscopy 
UV/Visible electronic spectra (300 nm – 700 nm) were acquired on a Perkin-Elmer U-3100 
using a 10 mm pathlength cuvette.  
 
2.5 Circular dichroism (CD) Spectroscopy 
CD spectra were collected on a Jasco J810 spectrometer. Spectra were routinely collected 
over the range 300 nm to 700 nm using a 10 mm cuvette with sampling every 1 nm. A 
minimum of 10 spectra were obtained and averaged, prior to smoothing using an 11-point 
moving average method in the Jasco software. 
 
2.6 Electron Paramagnetic Resonance (EPR) Spectroscopy 
Continuous wave EPR spectra at ~9.4 GHz (X-band) were obtained on a Bruker Elexsys 
E500 spectrometer operated with Bruker Xepr software and equipped with a super high-Q 
cavity. Calibration of the field was achieved using an ER036TM teslameter and the 
microwave frequency was calibrated with an EIP548B frequency counter. Stable 
temperatures of 150 ± 5K were achieved using a nitrogen gas flow through system linked to a 
Eurotherm B-VT-2000 variable temperature controller. Instrument settings were: modulation 
frequency 100 kHz; modulation amplitude 0.63G; microwave power 10 – 20 mW; number of 
scans 40 – 60; time constant 5.12 ms; sweep time 84 s. Spectra were baseline corrected using 
a polynomial function and high frequency noise was removed using Fourier filtering 
available in the Xepr software. Spectra were simulated using the least-squares fitting 
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algorithm in Easyspin running in Matlab R2014a [31]. The copper hyperfine and Zeeman 
interactions were initially simulated using matrix diagonalization, and perturbation theory 
was used after inclusion of nitrogen nuclei to simulate the nitrogen superhyperfine 
interactions. Where the presence of multiple absorbing species was apparent (i.e. 
[CuIILHSALPF-NH2]) the magnetic parameters were estimated directly from the spectrum. 
Linewidths were fit using a correlated distribution of g- and A-values [32].   
   
2.7 Nuclear Magnetic Resonance (NMR) Spectroscopy 
NMR spectra were acquired on a Bruker Avance 500 MHz spectrometer equipped with a 5 
mm TXI BBI probe and controlled using TopSpin 2.1 (Bruker Biospin, Germany). Samples 
were prepared in 90% H2O/10% D2O and the pH was adjusted using aliquots of concentrated 
HCl or NaOH. Proton spectra were acquired over a 10 ppm spectral width comprising 64K 
complex points, and the residual water signal was supressed using a W5 watergate sequence.  
Spectra were processed using a S/2 shifted sine squared window function in SpinWorks 4 
[33]. 
     
  
12 
 
3.0 Results 
3.1 Identification of novel SALMFamide precursor sequences    
Sequences encoding SALMFamide precursors have been identified previously in 
species representing each of the five classes in Echinodermata [17, 18]. These include 
sequences from Patiria miniata (Class Asteroidea; Order Valvatida), Luidia senegalensis 
(Class Asteroidea; Order Paxillosida), Ophionotus victoriae (Class Ophiuroidea; Order 
Ophiurida), Ophiothrix angulata (Class Ophiuroidea; Order Ophiurida), Strongylocentrotus 
purpuratus (Class Echinoidea; Order Echinoida), Lytechinus variegatus (Class Echinoidea; 
Order Temnopleuroida), Apostichopus japonicus (Class Holothuroidea; Order 
Aspidochirotida), Leptosynapta tenuis (Class Holothuroidea; Order Apodida) and Antedon 
mediterranea (Class Crinoidea; Order Comatulida) and Aporometra wilsoni (Class Crinoidea; 
Order Comatulida). 
Here, by analysis of new transcriptome sequence data, we have identified 
SALMFamide precursors in other echinoderm species, which include Asterias rubens (Class 
Asteroidea, Order Forcipulatida), Remaster gourdoni (Class Asteroidea, Order Velatida), 
Ophioderma brevispinum (Class Ophiuroidea, Order Ophiurida), Astrophyton muricatum 
(Class Ophiuroidea, Order Euryalida), Arbacia punctulata (Class Echinoidea, Order 
Arbacioida), Eucidaris tribuloides (Class Echinoidea, Order Cidaroida), Psolus spp (Class 
Holothuroidea; Order Dendrochirotida), Stichopus chloronatus (Class Holothuroidea; Order 
Aspidochirotida), Pannychia moseleyi (Class Holothuroidea, Order Elasipodida), Isometra 
vivipara (Class Crinoidea, Order Comatulida) and Oligometra serripinna (Class Crinoidea, 
Order Comatulida). 
 
3.2 Comparative analysis of echinoderm SALMFamide neuropeptide sequences: 
identification of conserved histidine residues  
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 Determination of the sequences of SALMFamide precursors in species from each of 
the five echinoderm classes enabled comparison of the sequences of the constituent 
neuropeptides and identification of conserved characteristics. Thus, Figure 1 shows C-
terminally aligned neuropeptides derived from L-type SALMFamide precursors in asterozoan 
and echinozoan species, with data from three species in each class shown. The presence of a 
leucine or an isoleucine residue (highlighted in red) in the third position from the C-terminal 
amide is characteristic feature of the majority of the neuropeptides, as expected for L-type 
SALMFamide precursor derived peptides. Furthermore, another conserved feature is the 
presence of a histidine residue (highlighted in turquoise) in the sixth position from the C-
terminal amide, with at least one of the peptides in all but one of the twelve species having 
this feature. However, it is most strikingly apparent in starfish species, where six out of seven 
or five out of six of the SALMFamides have this characteristic. With respect to the N-
terminus, the position of the conserved histidine residue is variable, ranging from position 
two to position eight. However, in starfish four of the five or six peptides with a histidine 
residue have the histidine in the third position from N-terminus. This is noteworthy because, 
as highlighted in the introduction, the presence of a histidine residue in this position is known 
to confer on peptides and proteins the ability to bind copper and nickel ions with high 
affinity. Hence, the H2N-xxH motif is known as an Amino Terminal Cu(II), Ni(II) Binding 
(ATCUN) motif. 
 
<<INSERT FIGURE 1>>  
 
Having identified the occurrence of conserved histidine residues in SALMFamides 
derived from L-type precursors, we investigated if this is also a conserved feature of 
SALMFamides derived from F-type precursors. Thus, Figure 2 shows C-terminally aligned 
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neuropeptides derived from F-type SALMFamide precursors in asterozoan and echinozoan 
species, with data from three species in each class shown. The presence of a phenylalanine 
residue or a structurally similar tyrosine residue (highlighted in yellow) in the third position 
from the C-terminal amide is a characteristic feature of the majority of the neuropeptides, as 
expected for F-type SALMFamide precursor derived peptides. However, unlike in L-type 
SALMFamide precursor derived peptides, histidine residues are not prevalent in F-type 
SALMFamide precursor derived peptides (Fig. 2) and only one peptide (in the sea urchin 
Arbacia punctulata) has a histidine residue in the sixth position from the C-terminal amide. 
 
<<INSERT FIGURE 2>>  
 
Lastly, we analysed the sequences of neuropeptides derived from the singular 
SALMFamide precursors that have been identified in crinoids. This revealed an interesting 
pattern in the occurrence of histidine residues, with conserved histidines present in L-type 
peptides located at the extremities of the precursors. Thus, in all three crinoid species 
analysed here, the first and last neuropeptide in the precursor proteins is an L-type 
SALMFamide with a histidine residue located at the sixth position from the C-terminal 
amide, a feature that they share with the majority of SALMFamides derived from L-type 
SALMFamide precursors in asterozoan and echinozoan species (Fig. 3). By way of contrast, 
the twelve neuropeptides that form the core of the crinoid SALMFamide precursors mostly 
have phenylalanine, tyrosine or leucine residues at position three with respect to the C-
terminal amide and typically do not have histidine residues. The occurrence at the extremities 
of crinoid SALMFamide precursors of L-type SALMFamides that have a histidine residue at 
position six with respect to C-terminal amide is interesting because it suggests that peptides 
with these characteristics may have given rise to the structurally related peptides that are 
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found in asterozoan and echinozoan L-type SALMFamide precursors. Accordingly, our data 
indicate that the evolutionary origin of L-type SALMFamides with a conserved histidine 
residue at position six with respect to the C-terminal amide can be traced back to the common 
ancestor of extant echinoderms. However, it is in the Asteroidea that peptides with this 
characteristic are most prevalent and furthermore the histidine typically occupies the third 
position from the N-terminus, forming a potential Cu(II) and Ni(II) binding site. This feature 
of SALMFamides derived from the L-type SALMFamide precursor in starfish is interesting 
from an evolutionary and functional perspective and therefore, as described below, we have 
investigated if these peptides do indeed bind Cu(II) and Ni(II) ions. To do this we synthesized 
and analysed neuropeptides derived from the L-type SALMFamide precursor in the common 
European starfish A. rubens.  
 
<<INSERT FIGURE 3>> 
 
3.3 Determination of the sequence of a cDNA encoding the L-type SALMFamide 
precursor in A. rubens 
 Cloning and sequencing of a 1028 bp cDNA encoding the A. rubens L-type 
SALMFamide precursor confirmed the predicted amino acid sequence obtained from 
transcriptome sequence data. Thus, the A. rubens L-type SALMFamide precursor is a 210 
residue protein with a predicted 23-residue signal peptide and seven L-type SALMFamides 
that are bounded by dibasic cleavage sites (Fig.  S1). Four of these peptides (AYHSALPF-
NH2, AYHTGLPF-NH2, GYHSALPF-NH2 and GYHSGLPF-NH2) contain the ATCUN 
motif H2N-xxH (Fig. 1 and S1). Two other peptides (PAGASAFHSALSY-NH2 and 
LHSALPF-NH2) contain a histidine residue but it is not in the third position from the N-
terminus, whilst the peptide S1 (GFNSALMF-NH2) lacks a histidine residue altogether.  
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3.4 Electronic and circular dichroism spectroscopy highlights coordination of copper 
and nickel to L-type SALMFamides      
To investigate the copper binding ability of peptides derived from the A. rubens L-
type SALMFamide precursor, we chose three representative peptides potentially containing 
copper sites: AYHSALPF-NH2, GYHSGLPF-NH2 and LHSALPF-NH2. We initially used 
electronic spectroscopy to probe metal binding. Figure 4A shows the spectra obtained after 
titration of Cu2+ or Ni2+ into AYHSALPF-NH2. Addition of Cu2+ to AYHSALPF-NH2 gives 
rise to an absorption band centred on 520 nm and the intensity tends to stop increasing with 
copper addition at around one equivalent (Fig. 4B). An absorption maximum of 520 nm is 
indicative of Cu2+ bound with only nitrogen coordination [2]. Titration of Ni2+ generates an 
absorption band at 420 nm (Fig. 4A) and, in contrast to Cu2+, the slope of the binding curve 
changes, rather than plateauing, at one equivalent (Fig. 4B). A peak at 420 nm is suggestive 
of Ni2+ bound in a square-planar, four-coordinate geometry [34]. Both the stoichiometry and 
wavelength maxima of Cu2+ and Ni2+ binding are entirely consistent with coordination of 
these metals to an ATCUN site. As expected, titration of these metals into GYHSGLPF-NH2 
produced identical results (Fig. 4C, D). The ATCUN motif generally binds copper and nickel 
via the N-terminal nitrogen, the histidine imidazole nitrogen, and intervening amide nitrogens 
(i.e. {Na, 2N-, NIm}) and therefore the nature of the amino acid side chains is of less 
importance, especially in this case where only the presence of a glycine or alanine 
differentiates the motif in AYHSALPF-NH2 and GYHSGLPF-NH2. A feature of an ATCUN 
site is the lack of changes to the absorption maximum as a function of pH [2]. Accordingly, 
the maximum wavelength of [CuIIGYHSGLPF-NH2] (520 nm) remains constant from ~ pH 5 
(Fig. S2A). In contrast to AYHSALPF-NH2 and GYHSGLPF-NH2, titration of Cu2+ into 
LHSALPF-NH2 generates a peak at 600 nm, but, similar to the previous peptides, the 
absorbance plateaus at around one equivalent Cu2+ (Fig. 4E, F). An absorbance at 600 nm 
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suggests this peptide contains one or more oxygen ligands in its coordination sphere. A pH 
titration of this peptide shows the 600 nm wavelength maximum remains constant until 
higher pH values (> pH 9) where increasing absorption at wavelengths <600 nm suggests 
incorporation of an additional nitrogen donor (Fig. S2B) [28]. 
 
<<INSERT FIGURE 4>> 
 
  To further examine the copper binding sites we used NMR. The presence of low 
concentrations of paramagnetic Cu2+ tends to broaden peaks associated with protons lying 
within ~7Å of the metal. Addition of ~0.1 equivalent Cu2+ to GYHSGLPF-NH2 results in 
selective broadening of the C2H (7.68 ppm) and C4H (6.92 ppm) protons of the imidazole 
ring (Fig. 5A) which tends to confirm His3 is a nitrogen donor. Some broadening of peaks 
due to the His3 HE protons (~3.61 ppm, shifted downfield due to ring current effects of Tyr2) 
is also observed (see Fig. S3 for expanded regions). Coordination of copper to the His3 amide 
and imidazole nitrogen (NG) could account for the perturbation of the beta protons. 
Additionally, peaks due to Tyr2 HE protons also show some broadening consistent with 
coordination to the nearby amide of Tyr2 (Fig. 5A, Fig. S3). In a similar manner addition of 
Cu2+ to LHSALPF-NH2 results in a loss of peaks due to histidine imidazole protons (Fig. 
5B). It is difficult to assess changes to the His3 HE peaks (~ 3.15 ppm, Fig. 5B) given overlap 
with Phe8 HE. A change in both the broadness and chemical shift is readily observed for the 
Leu1 HE peaks (~1.6 ppm), and to some extent the HG peaks (~0.9 ppm) (Fig. S3B), which 
suggests coordination to the nearby amide nitrogen of the amino acid. Intriguingly, despite 
having the same ratio of copper to peptide in both GYHSGLPF-NH2 and LHSALPF-NH2 the 
His imidazole peaks in the [CuIILHSALPF-NH2] sample have completely broadened and 
disappeared, but remain to some extent in the [CuIIGYHSGLPF-NH2] sample (Fig. 5). This 
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suggests that the different copper-binding sites in these peptides have different copper on/off 
rates (on the NMR timescale) with [CuIILHSALPF-NH2] at a comparatively faster rate than 
[CuIIGYHSGLPF-NH2]. The C2H and C4H peaks observed in the slowly exchanging 
[CuIIGYHSGLPF-NH2] spectrum (Fig. 5A) presumably arise from the apo form of the 
complex.         
 
<<INSERT FIGURE 5>> 
 
We next analysed the copper-complexes by circular dichroism (CD) spectroscopy. 
CD spectroscopy is a useful tool to analyse Cu2+ complexes because the d-d transitions that 
overlap to give a single broad peak in electronic spectroscopy can often be resolved into 
positive and negative peaks in CD [35]. The CD spectrum of [CuIIGYHSGLPF-NH2] is 
shown in Figure 6A (the spectrum of [CuIIAYHSALPF-NH2] has identical bands and is not 
shown). Positive bands are apparent at 316 nm and 490 nm and a weaker negative band 
appears at 570 nm. The bands at 490 nm and 570 nm can be attributed to d-d transitions, 
whereas a band around 320 nm may be attributed to an amide nitrogen → Cu2+ charge 
transfer (CT). In line with the absorption spectroscopy, the intensity of the bands tends to 
stop increasing at one equivalent Cu2+ (Fig. 6B). The visible CD spectrum of 
[CuIIGYHSGLPF-NH2] is strikingly similar to the copper-bound peptides GGH and DAHK, 
as well as that of copper-bound full length human serum albumin, suggesting similar 
coordination in all [35, 36]. The ATCUN motif is known to have high affinity for copper (Kd 
~ 10-12 – 10-14 M) and should out-compete the weaker copper chelator glycine [37]. Titration 
of [CuIIGYHSGLPF-NH2] with glycine (up to 7× molar excess vs. copper) caused no 
apparent change to the CD spectrum of [CuIIGYHSGLPF-NH2] which tends to support 
binding via a high affinity ATCUN motif (data not shown). Further analysis of the copper 
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affinity of the SALMFamide peptides was not undertaken. The CD spectra obtained during a 
Cu2+ titration of LHSALPF-NH2 are shown in Figure 6C. The spectra have a negative peak at 
300 nm, a positive peak at 346 nm and a broad positive feature around 600 nm, and all are 
relatively low intensity and largely identical to the CD spectrum of [CuIIGHK] [36]. The peak 
at 300 nm may be attributed to an amide nitrogen → Cu2+ CT, whereas the 346 nm peak is 
likely due to an imidazole nitrogen → Cu2+ CT, which is further supported by an absence of 
this peak in copper-bound tripeptides that lack a histidine [28, 35]. 
 
<<INSERT FIGURE 6>> 
 
3.5 EPR spectroscopy predicts presence of a copper-linked ternary complex between 
GYHSGLPF-NH2 and LHSALPF-NH2.  
The X-band (~9 GHz) EPR spectra of [CuIIGYHSGLPF-NH2] and [CuIILHSALPF-
NH2], each with a Cu2+:peptide ratio of 0.96, are shown in Figure 7A and 7B respectively 
(the spectrum of [CuIIAYHSALPF-NH2] is identical to that of [CuIIGYHSGLPF-NH2] and is 
not shown) . The EPR spectra for both reveal an axially symmetric Cu(II) centre (i.e. gx   gy 
z gz). For [CuIIGYHSGLPF-NH2] nitrogen superhyperfine (shf) coupling is apparent in the 
gx, gy (perpendicular, g┴ ) region between 315 – 350 mT and analysis of the characteristic 
parallel gz and Az(63Cu) values suggests that the copper ion is in a 4-nitrogen environment 
(Table 1) at this pH (7.2) [38]. In [CuIILHSALPF-NH2], the peak at g┴ is considerably 
broadened, suggesting the presence of multiple species, however some nitrogen coupling is 
apparent. The presence of multiple species is supported by Cu(II) speciation studies with 
GHK where the presence of mono- and bis-complexes was indicated at pH values similar to 
those used here [3]. The parallel values (Table 1) of [CuIILHSALPF-NH2] are different to 
those of [CuII(GYHSGLPF-NH2)] and suggest inclusion of oxygen donors which has 
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increased gz and decreased Az relative to that observed for [CuIIGYHSGLPF-NH2]. Most 
likely the predominant [CuIILHSALPF-NH2] species contains a CuN2O2 site which previous 
work suggests has average values of gz = 2.238 – 2.265 and Az   0.0182 – 0.0187 cm-1 and is 
consistent with the electronic spectrum (Fig. 1E) [39].  When apo-GYHSGLPF-NH2 is added 
to [CuIILHSALPF-NH2] such that the peptides are equimolar (i.e. [Cu]:[total peptide] is 
~0.5:1) then the spectrum in figure 7C is obtained. In this case the spectrum was best fit with 
CuII in a rhombically distorted environment (i.e. gx z gy z gz). The gz and Az values are 
different to those of the pure copper-peptides and suggest that an additional nitrogen atom/s 
has been added to the coordination sphere [38]. Nitrogen coupling is not observed on the 
parallel components of the spectrum, however, compared to [CuIILHSALPF-NH2] the 
linewidth in the perpendicular region has narrowed and the nitrogen shf coupling is more 
apparent. To improve resolution at gx,y the spectrum was differentiated and the expanded 
region (Fig. 7c) reveals the 14N shf coupling in more detail. Theoretically, each copper 
hyperfine coupling is split into (2nI + 1) (I =1) lines, where n is the number of magnetically 
equivalent nitrogen ligands. Although it is instructive to examine the features at g┴, in reality 
the number of lines is complicated by various factors such as the presence of multiple 
species, non-equivalent nitrogens and overlap with parallel features [40]. The experimental 
[CuIILHSALPF-NH2] + apo-GYHSGLPF-NH2 spectrum (Fig. 7c, exp) was fit assuming four 
and three nitrogens and the results (Fig. 7c 4N, 3N) suggest that the most likely coordination 
involves four nitrogen ligands. In neither case are the lines on the low field (320 – 325 mT) 
side of g┴ well simulated, however on the high field side (335 – 338 mT) the four nitrogen 
simulation clearly fits the experimental spectrum more closely in both the line position and 
intensity than the three nitrogen simulation. The high field transitions are known to be 
particularly sensitive to the number of nitrogen ligands [40]. Thus, we predict that the 
predominant species formed when apo-GYHSGLPF-NH2 is added to [CuIILHSALPF-NH2] 
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has CuII in a four-nitrogen environment. The EPR spectrum does not resemble 
[CuIIGYHSGLPF-NH2] indicating that apo-GYHSGLPF-NH2 has not just abstracted all the 
copper from [CuIILHSALPF-NH2]. It is likely that the oxygen donors observed in 
[CuIILHSALPF-NH2] have been replaced by nitrogens from apo-GYHSGLPF-NH2 to form a 
copper-linked ternary complex. We predict that the histidine imidazole from GYHSGLPF-
NH2 is a nitrogen contributor the ternary complex. This result is not unprecedented, as a 
previous study showed addition of the amino acid histidine to a solution of [CuIIGHK] 
generated a 4N complex where the oxygen donor in [CuIIGHK] was displaced by a nitrogen 
from the histidine imidazole group [36]. Collection of spectra at alternative frequencies, such 
as S-band (~ 4 GHz) which avoids broadening due to g- and A-strain correlations, may allow 
nitrogen coupling to be more completely analysed.                  
We next wondered that if [CuIILHSALPF-NH2] can form 4N complexes with apo-
GYHSGLPF-NH2, then why does copper titration of LHSALPF-NH2 by UV/Vis 
spectroscopy (Fig. 4E, F) show a simple 1:1 stoichiometry with a peak at 600 nm indicative 
of N/O coordination, when the 4N mononuclear binary complex [CuII(LHSALPF-NH2)2] can 
presumably be formed? Given that NMR shows different copper on/off rates for the 
complexes then maybe the timescale of the UV/Vis experiment accounts for the observed 
result. To explore this [CuIILHSALPF-NH2] (Fig. 7D) was scanned, left at room temperature 
for 2 hours then re-scanned. The resultant spectrum (Fig. 7D) shows that the d-d transitions 
are now much broader than in the initial sample and there is increased absorption at 
wavelengths shorter than 600 nm (no evidence of aggregation was observed). Taken together 
with the EPR data, this suggests that initially a simple [CuIILHSALPF-NH2] complex with a 
2N2O donor set is formed, but over time other species such as a 4N [CuII(LHSALPF-NH2)2] 
having absorption around 500 nm also occur. Along with ternary complexes, these species 
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may also contribute to the EPR spectrum (Fig. 7c) which increases the difficulty of accurately 
simulating the nitrogen coupling.   
 
<<INSERT FIGURE 7>> 
 
4.0 Discussion 
In this study we analysed SALMFamide neuropeptide precursor sequences from 
species belong to the five extant classes of the phylum Echinodermata and established that 
peptides derived from the L-type SALMFamide precursor in starfish (class Asteroidea) were 
over represented with the N-terminal sequence H2N-xxH. This sequence is a well-known 
copper-binding site termed an ATCUN-motif and suggested that these peptides should bind 
the metal. Using a range of spectroscopic techniques we show that the L-type SALMFamides 
in the starfish species A. rubens that contain the motif (e.g. GYHSGLPF-NH2) do indeed bind 
Cu(II) as well as Ni(II) ions. Taken together, the spectroscopic evidence indicates Cu(II) 
binding to these peptides involves the His3 imidazole nitrogen, the N-terminal nitrogen and 
intervening amide nitrogen atoms. Ni(II) binds in a similar manner resulting in a square-
planar diamagnetic complex. In addition, we show that LHSALPF-NH2, a heptapeptide 
derived from the A. rubens L-type SALMFamide precursor, can also bind copper but instead 
of four nitrogen atoms as ligands the complex initially includes oxygen atoms. Displacement 
of the oxygen ligand/s in the presence of GYHSGLPF-NH2 resulted in the formation of a 
copper-linked ternary complex (a heterodimer). To the best of our knowledge, this is the first 
study to report the identification of a neuropeptide precursor that contains multiple Cu(II)-
binding neuropeptides.  
 Comparative analysis of the sequences of SALMFamide precursors in echinoderms 
has provided a basis for investigation of the evolutionary history of the histidine residue that 
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confers on starfish L-type precursor-derived SALMFamides the ability to bind Cu(II) ions. 
Crinoids, which occupy a basal position in echinoderm phylogeny, appear to have only a 
single SALMFamide precursor, unlike asterozoans (starfish, brittlestars) and echinozoans 
(sea urchins, sea cucumbers), which have an L-type and F-type SALMFamide precursor (Fig. 
8). The crinoid SALMFamide precursor contains a core of twelve peptides that include F-
type-like SALMFamides. However, at both the N- and C-terminal extremities of the 
precursor there are single L-type SALMFamides that have a histidine residue in the sixth 
position from the C-terminus, in common with the majority of SALMFamides derived from 
L-type precursors in asterozoans and echinozoans. We postulate, therefore, that following 
duplication of a SALMFamide precursor gene in a common ancestor of the Asterozoa and 
Echinozoa, one copy retained the L-type peptides with a histidine residue at position six with 
respect to the C-terminal amide, lost other peptides and then gave rise to the L-type 
SALMFamide precursors that occur in extant asterozoans and echinozoans. Conversely, the 
other copy retained the core peptides that do not have conserved histidine residues, lost the L-
type peptides with a histidine residue at position six with respect to the C-terminal amide and 
then gave rise to the F-type SALMFamide precursors that occur in extant asterozoans and 
echinozoans. In surveying the occurrence in echinoderms of L-type SALMFamides with a 
histidine residue at position six with respect to the C-terminal amide, it is striking that in 
starfish (Asteroidea) these peptides are most abundant and have acquired the ATCUN motif 
by virtue of the histidine occupying the third position from the N-terminus (Fig. 8).  
 
<<INSERT FIGURE 8>> 
 
The concentration of free copper ions in seawater is estimated in the range of 10-11 – 
10-13 M, whilst the total dissolved copper concentration, which includes organically 
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complexed copper, is ~ 10-8 M [41-43]. It is likely that the copper content of the extracellular 
milieu in starfish is similar to that of seawater because these animals, like other marine 
invertebrates, are osmoconformers. Therefore, upon release from neurons L-type 
SALMFamides are likely to encounter copper ions at concentrations near the Kd established 
for ACTUN motif-containing peptides (10-12 – 10-14 M [37]) and therefore will compete for 
copper ions, even when taking into consideration the ligands present in seawater which can 
have high binding constants [42]. Interestingly, the SALMFamides, like other amidated 
neuropeptides, traffic through the Golgi network where they are C-terminally amidated by the 
copper-metalloenzyme peptidyl-glycine alpha-amidating monooxygenase [44]. The trans-
Golgi contains copper because several proteins are loaded with copper in this cellular 
compartment during their biosynthesis. Although copper is pumped into the trans-Golgi as 
Cu+ by the Menkes ATPase [45], it is not clear whether it stays as Cu+ or if there is some 
oxidation to Cu2+. It is therefore interesting to speculate that, rather than being metallated 
after release, L-type SALMFamides containing an ATCUN motif may in fact have copper 
already bound to them prior to release from starfish neurons. 
At the molecular level, how may the presence of bound Cu(II) ions affect the 
bioactivity of L-type SALMFamides? Our previous studies on the prototypical 
SALMFamides S1 and S2, L-type SALMFamides that do not bind metal, indicate that their 
bioactivity is primarily determined by the C-terminal region of the peptides. The N-terminal 
tetrapeptide of S2 (SGPY) does, however, influence peptide structure by causing S2 to self-
associate at high concentrations and form highly-structured multimers [15]. We predicted that 
S2’s structure and activity may change as it diffuses away from sites of release and becomes 
less concentrated. Further, addition of the SGPY tetrapeptide to the N-terminus of S1 confers 
structure on this chimeric peptide that is not observed with the S1 peptide. Now we show that 
the L-type SALMFamide precursor-derived peptide LHSALPF-NH2 can form a copper-
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linked ternary complex (a heterodimer) with GYHSGLPF-NH2, and the chemistry suggests 
that LHSALPF-NH2 will form similar ternary complexes with any of the ATCUN-containing 
L-type SALMFamides. The formation of these copper complexes (monomers and dimers) 
may modify receptor binding or make the peptides more resistant to proteolysis. Interestingly, 
evidence that copper binding affects enzymatic degradation of neuropeptides has been 
reported recently. Herman et al. [46] reported that human gonadotropin-releasing hormone 
(GnRH), which has a histidine residue at position two, binds Cu2+ ions and this confers on 
GnRH increased resistance to enzymatic degradation in extracts of hypothalamic and 
pituitary tissue. Accordingly, the copper-linked ternary complexes of LHSALPF-NH2 and 
ACTUN motif-containing L-type SALMFamides may likewise be more resistant to 
enzymatic degradation than the monomeric peptides in the absence of copper.  
At the physiological level, previous studies have revealed that SALMFamide 
neuropeptides S1 and S2 cause dose-dependent relaxation of the starfish cardiac stomach in 
vitro and trigger cardiac stomach eversion in vivo (Melarange et al., 1999). This 
pharmacological effect of SALMFamides is of interest because starfish feed by everting their 
cardiac stomach over prey and partially digesting prey tissue externally. Therefore, it is 
proposed that SALMFamides may mediate neural control of cardiac stomach eversion during 
starfish feeding behaviour [12]. Furthermore, extraoral feeding is unique to starfish (Class 
Asteroidea) amongst extant echinoderms [47]. We speculate, therefore, that the acquisition 
and proliferation of L-type SALMFamides that have an ATCUN motif and bind copper ions 
in starfish may be associated with a role in regulating stomach eversion. For example, the 
secretion of proteases by cells in the mucosal epithelium of the cardiac stomach during 
feeding creates a proteolytic environment [47], which may have favoured acquisition of 
structural characteristics that protect SALMFamides from aminopeptidases. Therefore, in this 
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context, our findings may provide a basis for experimental studies in which the physiological 
significance of copper-binding neuropeptides could be further investigated. 
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Figure Legends 
 
Figure 1. C-terminally aligned sequences of SALMFamide neuropeptides derived from L-
type SALMFamide precursors in the Asteroidea (Patiria miniata, Asterias rubens and 
Remaster gourdoni) [1], Ophiuroidea (Ophionotus victoriae, Ophioderma brevispinum and 
Ophiothrix angulata [2], Echinoidea (Strongylocentrotus purpuratus, Arbacia punctulata and 
Eucidaris tribuloides) [3] and Holothuroidea (Apostichopus japonicus, Psolus spp and 
Pannychia moseleyi) [4]. The third amino acid residue from the C-terminal amide has been 
highlighted in red if it is leucine or isoleucine, yellow if phenylalanine or tyrosine and grey if 
any other residue. Histidine residues located in the sixth position from C-terminal amide have 
been highlighted in turquoise.  
Figure 2. C-terminally aligned sequences of SALMFamide neuropeptides derived from from 
F-type SALMFamide precursors in the Asteroidea (Patiria miniata, Asterias rubens and 
Remaster gourdoni) [1], Ophiuroidea (Ophionotus victoriae, Astrophyton muricatum and 
Ophiothrix angulata [2], Echinoidea (Strongylocentrotus purpuratus, Arbacia punctulata and 
Lytechinus variegatus) [3] and Holothuroidea (Apostichopus japonicus, Psolus spp and 
Stichopus chloronatus) [4]. The third amino acid residue from the C-terminal amide has been 
highlighted in red if it is leucine or isoleucine, yellow if phenylalanine or tyrosine and grey if 
any other. Histidine residues located in the sixth position from C-terminal amide have been 
highlighted in turquoise. 
Figure 3. SALMFamide neuropeptides derived from SALMFamide precursors in the 
Crinoidea (Antedon mediterranea, Isometra vivipara and Oligometra serripinna). The third 
amino acid residue from the C-terminal amide has been highlighted in red if it is leucine or 
isoleucine, yellow if phenylalanine or tyrosine and grey if any other residue. Histidine located 
in the sixth position from C-terminal amide residues have been highlighted in turquoise. 
Figure 4. Copper(II) and nickel(II) titrations monitored by electronic spectroscopy.  
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(A) Titration of Cu2+ (solid black line) into AYHSALPF-NH2 (100 PM, 10 mM nEM, pH 
7.44) results in the formation of a peak at 520 nm. Titration of Ni2+ (dashed red line) results 
in an increase in absorption at 420 nm. (B) Plots of the absorbance at 520 nm (Cu2+) and 420 
nm (Ni2+) as a function of added metal. Both curves plateau around 100 PM metal, 
suggesting 1:1 stoichiometry. (C) Titration of Cu2+ (solid black line) and Ni2+ (dashed red 
line) into GYHSGLPF-NH2 (80 PM, 10 mM nEM, pH 7.44) results in the formation of peaks 
at 520 nm and 420 nm, respectively. (D) Plots of the absorbance at 520 nm (Cu2+) and 420 
nm (Ni2+) as a function of added metal. Both curves plateau around 80 PM metal, suggesting 
1:1 stoichiometry. (E) Titration of Cu2+ into LHSALPF-NH2 (110 PM, 10 mM nEM, pH 
7.44) generates an absorption band at 600 nm and the binding curve (F) suggests a 
stoichiometry of 1:1.   
Figure 5.  Paramagnetic copper causes broadening of GYHSGLPF-NH2 and LHSALPF-NH2 
1H NMR spectra. (A) 1H NMR spectra of ~500 PM apo-GYHSGLPF- NH2 in 10% D2O/90% 
H2O, pH 7.2 (bottom trace) and after the addition of 0.1 equivalent Cu2+ (top trace). 
Assignment of selected perturbed peaks is shown in top trace. (B). 1H NMR spectra of ~500 
PM apo-LHSALPF- NH2 in 10% D2O/90% H2O, pH 7.2 (bottom trace) and after the addition 
of 0.1 equivalent Cu2+ (top trace). Assignment of selected perturbed peaks is shown in top 
trace. Expansion of assigned peaks in both A and B are shown in supplementary material 
figure S3. 
Figure 6. Copper(II) titrations monitored by circular dichroism spectroscopy. (A) CD spectra 
(300 – 700 nm) were collected as Cu2+ was titrated into apo-GYHSGLPF-NH2 (93 PM, 10 
mM nEM, pH 7.7). Peaks at 490 nm and 570 nm are due to d-d transitions and the peak in the 
near-UV (316 nm) can be attributed to an amide N-→ Cu(II) CT. (B) The intensity of the 
peaks at 316 nm (■) and 490 nm (x) plotted as a function of [Cu(II)]/[GYHSGLPF-NH2] 
plateaus at a ratio near one. (C) CD spectra obtained during a titration of apo-LHSALPF-NH2 
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(96 PM, 10 mM nEM, pH 7.7) with Cu2+ show low intensity peaks at 300 nm (amide N→ 
Cu(II) CT), 346 nm (imidazole N→ Cu2+ CT)  and 600 nm (d-d transition). (D) The intensity 
of the peaks at 300 nm (■) and 346 nm (x) plotted as a function of [Cu(II)]/[LHSALPF-NH2] 
plateaus at a ratio near one.   
Figure 7. X-band EPR spectra of CuII-bound peptides. (A) First derivative spectrum of 
[CuII(GYHSGLPF-NH2)] (Q = 9.433547, 262 PM, 10 mM nEM, pH 7.2, 0.98 equivalents 
Cu2+), dashed line is simulated spectrum, (B) first derivative spectrum of [CuII(LHSALPF-
NH2)] (Q = 9.433526, 1 mM, 10 mM nEM, pH 7.2, 0.96 equivalents Cu2+), (C) first 
derivative spectrum of a mixture of [CuII(LHSALPF-NH2)] (Q = 9.432792, 260 PM, 10 mM 
nEM, pH 7.2) and apo-GYHSGLPF-NH2 (243 PM,10 mM nEM, pH 7.2). Inset (c) shows the 
second derivative spectrum of (C) highlighting the perpendicular region (exp), along with the 
same region after simulation assuming four (4N) or three (3N) nitrogen donors. (D) Titration 
of Cu2+ into LHSALPF-NH2 (110 PM, 10 mM nEM, pH 7.44) generates an absorption band 
at 600 nm. Leaving the sample at room temperature for 2 hrs generated a spectrum with 
broadened d-d transitions.  
Figure 8. The occurrence and properties of SALMFamide precursors in species representing 
each of the five extant echinoderm classes. A. rub is the starfish Asterias rubens (Asteroidea), 
O. vic is the brittlestar Ophionotus victoriae (Ophiuroidea), S. pur is the sea urchin 
Strongylocentrotus purpuratus (Echinoidea), A. jap is the sea cucumber Apostichopus 
japonicus (Holothuroidea) and A. med is the feather star Antedon mediterranea (Crinoidea). 
Signal peptides are shown in blue, spacer peptides are in white, monobasic or dibasic 
cleavage sites are in green, SALMFamides with a C-terminal FXXamide motif are in yellow, 
a LXXamide motif are in red and a XXXamide motif are in grey. In addition, SALMFamides 
containing a histidine residue at the sixth position from the C-terminal amide are marked with 
H and peptides in which this histidine residue forms an ATCUN motif have been marked 
35 
 
with an asterisk. The data indicate that the common ancestor of all extant echinoderms had a 
single SALMFamide precursor, including histidine-containing L-type SALMFamides, as in 
extant crinoids. Then duplication (x2) of the SALMFamide precursor in the common ancestor 
of extant Eleutherozoa followed by divergence gave rise to two types of precursor: the L-type 
precursor, which typically includes SALMFamides with a conserved histidine residue, and 
the F-type precursor. Figure modified from Elphick et al. [17]. 
 
 
 
Table 1. Spin Hamiltonian parameters for CuIISALMFamide peptides. 
 
Complex gx gy gz Ax (63Cu)a  Ay (63Cu)a  Az (63Cu)a  
[CuII(GYHSGLPF-NH2)] 2.044 2.044 2.176 22.1 22.1 200.9 
[CuII(LHSALPF-NH2)] 2.042 2.042 2.220 - - 187.5 
[CuII(LHSALPF-NH2) + 
apoGYHSGLPF-NH2 
2.045 2.067 2.207 11.5 12.1 197.3 
a. units 10-4 cm-1 
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Abstract 
Background 
Neuropeptides with an Amino Terminal Cu(II), Ni(II) Binding (ATCUN) motif (H2N-xxH) 
bind Cu(II)/Ni(II) ions. Here we report the novel discovery of a neuropeptide precursor that 
gives rise to a “cocktail” of peptides that bind Cu(II)/Ni(II) and form ternary complexes – the 
L-type SALMFamide precursor in the starfish Asterias rubens. 
Methods 
Echinoderm transcriptome sequence data were analysed to identify transcripts encoding 
precursors of SALMFamide-type neuropeptides. The sequence of the L-type SALMFamide 
precursor in the starfish Asterias rubens was confirmed by cDNA sequencing and peptides 
derived from this precursor (e.g. AYHSALPF-NH2, GYHSGLPF-NH2 and LHSALPF-NH2) 
were synthesised. The ability of these peptides to bind metals was investigated using UV/Vis, 
NMR, circular dichroism and EPR spectroscopy. 
Results 
AYHSALPF-NH2 and GYHSGLPF-NH2 bind Cu(II) and Ni(II) and generate metal-linked 
dimers to form ternary complexes with LHSALPF-NH2. Investigation of the evolutionary 
history of the histidine residue that confers these properties revealed that it can be traced to 
the common ancestor of echinoderms, which is estimated to have lived ~500 million years 
ago. However, L-type precursors comprising multiple SALMFamides with the histidine 
residue forming an ATCUN motif appears to be a feature that has evolved uniquely in 
starfish (Asteroidea). 
General Significance 
The discovery of a SALMFamide-type neuropeptide precursor protein that gives rise to a 
“cocktail” of peptides that bind metal ions and generate metal-linked dimers provides a new 
insight on ATCUN motif-containing neuropeptides. This property of L-type SALMFamides 
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in the Asteroidea may be associated with a role in regulation of the unusual extra-oral feeding 
behavior of starfish.  
 
 
Keywords: ATCUN, SALMFamide, copper, neuropeptide, starfish, echinoderm  
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1.0 Introduction 
Neuropeptides are neuronal intercellular signalling molecules that act as 
neurotransmitters, neuromodulators or neurohormones and regulate many physiological 
processes and behaviours in humans and other animals [1]. They are derived from larger 
precursor proteins and are subject to post-translational modifications that are important for 
function; for example, in many neuropeptides a C-terminal glycine residue is converted to an 
amide group. Furthermore, in some neuropeptides the presence of a histidine residue can 
confer the ability to bind metal ions. In particular, the presence of an Amino Terminal Cu(II), 
Ni(II) Binding (ATCUN) motif, where a histidine residue is specifically located in the third 
position from the N-terminus (i.e. H2N-xxH, where x is variable), has been found to confer 
high affinity binding of Cu(II) and Ni(II). The ATCUN motif was originally characterized in 
albumins but subsequently it has been demonstrated that other peptides/proteins with an 
ATCUN motif also bind Cu(II) and/or Ni(II) ions [2, 3]. In 1995 Harford and Sarkar 
demonstrated that the mammalian neuropeptide neuromedin C, which has the N-terminal 
sequence Gly-Asn-His, binds both Cu(II) and Ni(II) specifically. Furthermore, the authors 
speculated that this property of neuromedin C may have relevance to neurological deficits 
associated with copper metabolism disorders, such as Menkes disease and Wilson disease [4]. 
More recently, Russino et al. reported that the mammalian tachykinin-type peptide 
neurokinin B, which contains an ATCUN motif, binds Cu(II) ions in an unusual 
[CuII(NKB)2] complex [5].  Furthermore, although Cu(II) binding substantially alters the 
structure of neurokinin B, the ability of [CuII(NKB)2] to activate the NKB receptor was not 
impeded. It was speculated that NKB may have a role in protecting cells from the effects of 
neuronally released copper. Several other members of the tachykinin peptide family have also 
been shown to coordinate copper ions, yet the physiological consequences remain to be 
determined [6, 7].   
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Here we report the novel discovery of a neuropeptide precursor protein that gives rise 
to a “cocktail” of neuropeptides that bind Cu(II) – the starfish L-type SALMFamide 
precursor. SALMFamide neuropeptides occur in species belonging to the phylum 
Echinodermata, which includes starfish, brittle stars, sea urchins, sea cucumbers and feather 
stars [8]. The first members of this neuropeptide family to be identified, S1 and S2, were both 
isolated from the starfish species Asterias rubens and Asterias forbesi. S1 is an octapeptide 
with the amino acid sequence GFNSALMF-NH2 and S2 is a dodecapeptide with the amino 
acid sequence SGPYSFNSGLTF-NH2 [9, 10]. Subsequently, SALMFamides were identified 
in other echinoderms, including GFSKLYF-NH2 and SGYSVLYF-NH2 from the sea 
cucumber Holothuria glaberrima and GYSPFMF-NH2 and FKSPFMF-NH2 from the sea 
cucumber Apostichopus japonicus [11]. Identification of these holothurian neuropeptides 
revealed the existence of two types of SALMFamides. Firstly, L-type SALMFamides that 
have the C-terminal motif SxLxF-NH2 (e.g. S1, S2, GFSKLYF-NH2 and SGYSVLYF-NH2) 
and secondly, F-type SALMFamides that have the C-terminal motif SxFxF-NH2 
(GYSPFMF-NH2 and FKSPFMF-NH2). 
 Investigation of the bioactivity of SALMFamides in echinoderms has revealed that 
both L-type and F-type SALMFamides act as muscle relaxants [12]. For example, S1 and S2 
both cause dose-dependent relaxation of apical muscle, tube foot and cardiac stomach 
preparations from the starfish A. rubens [13, 14]. Furthermore, S2 exhibits higher 
potency/efficacy than S1, which provided a rationale for investigation of a structural basis for 
this difference in bioactivity. By testing chimeric analogs of S1 and S2, it was found that it is 
the C-terminal region of the peptides that is the primary determinant of their differing 
potency/efficacy [15, 16]. However, the N-terminal tetrapeptide (SGPY) of S2 contributes to 
its bioactivity and confers on S2 the property to self-associate and form highly structured 
multimers at high concentrations [15]. Interestingly, addition of the SGPY tetrapeptide to the 
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N-terminus of S1 confers structure that is not observed with the S1 peptide, but without 
enhancing bioactivity. Thus, the differing bioactivity of S1 and S2 is determined by a 
complex interplay of sequence and conformation.  
 Advances in genome/transcriptome sequencing have enabled determination of the 
sequences of SALMFamide neuropeptide precursor proteins. For example, sequencing of the 
genome and transcriptome of the starfish Patiria miniata revealed: 1) an “L-type” precursor 
comprising S1 and six other L-type SALMFamides and 2) an “F-type” precursor comprising 
eight F-type or F-type-like SALMFamides and an S2-like peptide (L-type). Furthermore, 
comparative analysis of sequence data from a variety of echinoderm species has enabled 
investigation of the evolution of SALMFamide precursors [17, 18]. The phylum 
Echinodermata comprises five extant classes, Asteroidea (starfish), Ophiuroidea (brittle 
stars), Echinoidea (sea urchins, sand dollars), Holothuroidea (sea cucumbers) and Crinoidea 
(feather stars and sea lilies), and the phylogenetic relationships of these classes have been 
determined. Thus, the Asteroidea and Ophiuroidea are sister classes (the Asterozoa) and the 
Echinoidea and Holothuroidea are sister classes (the Echinozoa), with the Crinoidea basal to 
the Asterozoa and Echinozoa [19-26]. This phylogeny has provided a framework to 
reconstruct the evolution of SALMFamide precursors in the phylum Echinodermata. In 
crinoid species only a single SALMFamide precursor has been identified, whereas asterozoan 
and echinozoan species have both an L-type and an F-type precursor. It has therefore been 
postulated that the L-type and F-type precursors found in asterozoans and echinozoans may 
have arisen by duplication of a common ancestral-type precursor similar to that found in 
extant crinoids [17].       
 Here we have obtained additional sequences of SALMFamide precursors in 
echinoderm species representing the five extant classes. Comparative analysis of the 
sequences of echinoderm SALMFamide precursors revealed that several neuropeptides 
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derived from L-type SALMFamide precursors in starfish have an ATCUN motif. For 
example AYHSALPF-NH2, a neuropeptide that has been identified previously in the starfish 
species Marthasterias glacialis [27]. In addition, one of the peptides derived from L-type 
SALMFamide precursors in starfish (e.g. LHSALPF-NH2) has a histidine in the same 
position as the tripeptide Gly-His-Lys (GHK), a well-studied naturally occurring human 
copper-binding growth factor [28]. We show here that L-type SALMFamides in the starfish 
A. rubens that have an ATCUN motif are able to bind Cu(II) and Ni(II). Furthermore, Cu(II) 
binding to these peptides facilitates formation of ternary complexes with LHSALPF-NH2. 
The evolutionary and functional significance of these properties of neuropeptides derived 
from the L-type SALMFamide precursor in starfish is discussed. 
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2.0 Materials and Methods 
2.1 Transcriptome sequencing 
 The sequences of SALMFamide precursors have been determined in species 
representing all five echinoderm classes, as reported previously [17, 18]. Here we have 
obtained additional transcriptome sequence data from other species belonging to each of the 
five echinoderm classes: the starfishes Asterias rubens and Remaster gourdoni (class 
Asteroidea), the brittle stars Ophioderma brevispinum and Astrophyton muricatum (class 
Ophiuroidea), the sea urchins Arbacia punctulata and Eucidaris tribuloides (class 
Echinoidea), the sea cucumbers Psolus spp, Stichopus chloronatus and Pannychia moseleyi 
(class Holothuroidea) and the feather stars Isometra vivipara and Oligometra serripinna 
(class Crinoidea).  
Asterias rubens radial nerve cord transcriptome sequence data were obtained as 
reported previously [29]. For the other echinoderm species, RNA was extracted from tube 
feet (Remaster gourdoni), arms (Ophioderma brevispinum, Astrophyton muricatum), body 
wall (Arbacia punctulata, Eucidaris tribuloides, Psolus spp, Stichopus chloronatus, 
Pannychia moseleyi) or pinnules (Isometra vivipara, Oligometra serripinna) and then 
subjected to RNA-Seq sequencing on an Illumina Hiseq 2000 platform (100 base pairs, 
paired end). Reads for each of the samples were filtered by quality score (cutoff threshold > 
Q20) using fastxtrimmer and Illumina adapters were removed using fastxclipper, which are 
both components of the fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). De novo 
assembly of contigs was then performed using Trinity on a high memory computer cluster 
using 500 GB of RAM and 24 CPUs [30].   
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2.2 Cloning and sequencing of the L-type SALMFa precursor cDNA from A. rubens 
SALMFamides derived from the A. rubens L-type SALMFamide precursor were 
selected for the metal-binding studies described below. To facilitate this it was first necessary 
to confirm, by cDNA cloning and sequencing, the sequence of the precursor predicted from 
Illumina transcriptome sequencing. Total RNA from radial nerve cords of A. rubens was 
isolated using the Total RNA Isolation System (Promega) and used for cDNA synthesis using 
the Quantitect Reverse Transcription Kit (QIAgen). The full-length cDNA of the A. rubens 
L-type SALMFa precursor, including 5′ and 3′ untranslated regions (UTR), was amplified by 
PCR using Phusion high-fidelity PCR master mix (NEB) and the oligos 5′-
TAGCTACTTGACACA-3′ and 5′-ATATGACTAGTTGAGAGAGG-3′, which were 
designed using Primer3 software (http://bioinfo.ut.ee/primer3-0.4.0/). The PCR product was 
gel-extracted and purified using a QIAquick gel extraction kit (QIAgen) before being blunt-
end cloned into a pBluescript SKII (+) vector (Agilent Technologies) cut with a EcoRV-HF 
restriction endonuclease (NEB). The clone was then sequenced (Eurofins Genomics) from the 
T7 and pCR3.1-BGH-rev sequencing primer sites. 
 
2.3 Neuropeptide synthesis and metal titrations 
The A. rubens L-type SALMFamides AYHSALPF-NH2, GYHSGLPF-NH2 and 
LHSALPF-NH2 were synthesised by Synpeptide (Shanghai, China) and were >95% pure as 
determined by mass spectrometry and NMR. The lyophilized peptides were weighed and 
dissolved in the required buffer (10 mM nEM unless otherwise stated) on the day of use. The 
peptide concentration was estimated using the extinction coefficient of the single tyrosine 
amino acid (H280nm = 1280 M-1cm-1) or from the measured mass taking into consideration the 
presence of ~30% water. Stock (0.5 M) solutions of copper and nickel were prepared as 
CuCl2·2H2O and NiCl2·2H2O in water and diluted to working solutions on the day of use. 
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Metal addition during titrations was achieved using a 10 PL Hamilton gastight syringe. The 
spectrum of metal-free peptide was subtracted from the spectrum after each metal addition 
and dilution effects were taken into account during processing of the spectra.  
 
2.4 Electronic Spectroscopy 
UV/Visible electronic spectra (300 nm – 700 nm) were acquired on a Perkin-Elmer U-3100 
using a 10 mm pathlength cuvette.  
 
2.5 Circular dichroism (CD) Spectroscopy 
CD spectra were collected on a Jasco J810 spectrometer. Spectra were routinely collected 
over the range 300 nm to 700 nm using a 10 mm cuvette with sampling every 1 nm. A 
minimum of 10 spectra were obtained and averaged, prior to smoothing using an 11-point 
moving average method in the Jasco software. 
 
2.6 Electron Paramagnetic Resonance (EPR) Spectroscopy 
Continuous wave EPR spectra at ~9.4 GHz (X-band) were obtained on a Bruker Elexsys 
E500 spectrometer operated with Bruker Xepr software and equipped with a super high-Q 
cavity. Calibration of the field was achieved using an ER036TM teslameter and the 
microwave frequency was calibrated with an EIP548B frequency counter. Stable 
temperatures of 150 ± 5K were achieved using a nitrogen gas flow through system linked to a 
Eurotherm B-VT-2000 variable temperature controller. Instrument settings were: modulation 
frequency 100 kHz; modulation amplitude 0.63G; microwave power 10 – 20 mW; number of 
scans 40 – 60; time constant 5.12 ms; sweep time 84 s. Spectra were baseline corrected using 
a polynomial function and high frequency noise was removed using Fourier filtering 
available in the Xepr software. Spectra were simulated using the least-squares fitting 
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algorithm in Easyspin running in Matlab R2014a [31]. The copper hyperfine and Zeeman 
interactions were initially simulated using matrix diagonalization, and perturbation theory 
was used after inclusion of nitrogen nuclei to simulate the nitrogen superhyperfine 
interactions. Where the presence of multiple absorbing species was apparent (i.e. 
[CuIILHSALPF-NH2]) the magnetic parameters were estimated directly from the spectrum. 
Linewidths were fit using a correlated distribution of g- and A-values [32].   
   
2.7 Nuclear Magnetic Resonance (NMR) Spectroscopy 
NMR spectra were acquired on a Bruker Avance 500 MHz spectrometer equipped with a 5 
mm TXI BBI probe and controlled using TopSpin 2.1 (Bruker Biospin, Germany). Samples 
were prepared in 90% H2O/10% D2O and the pH was adjusted using aliquots of concentrated 
HCl or NaOH. Proton spectra were acquired over a 10 ppm spectral width comprising 64K 
complex points, and the residual water signal was supressed using a W5 watergate sequence.  
Spectra were processed using a S/2 shifted sine squared window function in SpinWorks 4 
[33]. 
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3.0 Results 
3.1 Identification of novel SALMFamide precursor sequences    
Sequences encoding SALMFamide precursors have been identified previously in 
species representing each of the five classes in Echinodermata [17, 18]. These include 
sequences from Patiria miniata (Class Asteroidea; Order Valvatida), Luidia senegalensis 
(Class Asteroidea; Order Paxillosida), Ophionotus victoriae (Class Ophiuroidea; Order 
Ophiurida), Ophiothrix angulata (Class Ophiuroidea; Order Ophiurida), Strongylocentrotus 
purpuratus (Class Echinoidea; Order Echinoida), Lytechinus variegatus (Class Echinoidea; 
Order Temnopleuroida), Apostichopus japonicus (Class Holothuroidea; Order 
Aspidochirotida), Leptosynapta tenuis (Class Holothuroidea; Order Apodida) and Antedon 
mediterranea (Class Crinoidea; Order Comatulida) and Aporometra wilsoni (Class Crinoidea; 
Order Comatulida). 
Here, by analysis of new transcriptome sequence data, we have identified 
SALMFamide precursors in other echinoderm species, which include Asterias rubens (Class 
Asteroidea, Order Forcipulatida), Remaster gourdoni (Class Asteroidea, Order Velatida), 
Ophioderma brevispinum (Class Ophiuroidea, Order Ophiurida), Astrophyton muricatum 
(Class Ophiuroidea, Order Euryalida), Arbacia punctulata (Class Echinoidea, Order 
Arbacioida), Eucidaris tribuloides (Class Echinoidea, Order Cidaroida), Psolus spp (Class 
Holothuroidea; Order Dendrochirotida), Stichopus chloronatus (Class Holothuroidea; Order 
Aspidochirotida), Pannychia moseleyi (Class Holothuroidea, Order Elasipodida), Isometra 
vivipara (Class Crinoidea, Order Comatulida) and Oligometra serripinna (Class Crinoidea, 
Order Comatulida). 
 
3.2 Comparative analysis of echinoderm SALMFamide neuropeptide sequences: 
identification of conserved histidine residues  
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 Determination of the sequences of SALMFamide precursors in species from each of 
the five echinoderm classes enabled comparison of the sequences of the constituent 
neuropeptides and identification of conserved characteristics. Thus, Figure 1 shows C-
terminally aligned neuropeptides derived from L-type SALMFamide precursors in asterozoan 
and echinozoan species, with data from three species in each class shown. The presence of a 
leucine or an isoleucine residue (highlighted in red) in the third position from the C-terminal 
amide is characteristic feature of the majority of the neuropeptides, as expected for L-type 
SALMFamide precursor derived peptides. Furthermore, another conserved feature is the 
presence of a histidine residue (highlighted in turquoise) in the sixth position from the C-
terminal amide, with at least one of the peptides in all but one of the twelve species having 
this feature. However, it is most strikingly apparent in starfish species, where six out of seven 
or five out of six of the SALMFamides have this characteristic. With respect to the N-
terminus, the position of the conserved histidine residue is variable, ranging from position 
two to position eight. However, in starfish four of the five or six peptides with a histidine 
residue have the histidine in the third position from N-terminus. This is noteworthy because, 
as highlighted in the introduction, the presence of a histidine residue in this position is known 
to confer on peptides and proteins the ability to bind copper and nickel ions with high 
affinity. Hence, the H2N-xxH motif is known as an Amino Terminal Cu(II), Ni(II) Binding 
(ATCUN) motif. 
 
<<INSERT FIGURE 1>>  
 
Having identified the occurrence of conserved histidine residues in SALMFamides 
derived from L-type precursors, we investigated if this is also a conserved feature of 
SALMFamides derived from F-type precursors. Thus, Figure 2 shows C-terminally aligned 
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neuropeptides derived from F-type SALMFamide precursors in asterozoan and echinozoan 
species, with data from three species in each class shown. The presence of a phenylalanine 
residue or a structurally similar tyrosine residue (highlighted in yellow) in the third position 
from the C-terminal amide is a characteristic feature of the majority of the neuropeptides, as 
expected for F-type SALMFamide precursor derived peptides. However, unlike in L-type 
SALMFamide precursor derived peptides, histidine residues are not prevalent in F-type 
SALMFamide precursor derived peptides (Fig. 2) and only one peptide (in the sea urchin 
Arbacia punctulata) has a histidine residue in the sixth position from the C-terminal amide. 
 
<<INSERT FIGURE 2>>  
 
Lastly, we analysed the sequences of neuropeptides derived from the singular 
SALMFamide precursors that have been identified in crinoids. This revealed an interesting 
pattern in the occurrence of histidine residues, with conserved histidines present in L-type 
peptides located at the extremities of the precursors. Thus, in all three crinoid species 
analysed here, the first and last neuropeptide in the precursor proteins is an L-type 
SALMFamide with a histidine residue located at the sixth position from the C-terminal 
amide, a feature that they share with the majority of SALMFamides derived from L-type 
SALMFamide precursors in asterozoan and echinozoan species (Fig. 3). By way of contrast, 
the twelve neuropeptides that form the core of the crinoid SALMFamide precursors mostly 
have phenylalanine, tyrosine or leucine residues at position three with respect to the C-
terminal amide and typically do not have histidine residues. The occurrence at the extremities 
of crinoid SALMFamide precursors of L-type SALMFamides that have a histidine residue at 
position six with respect to C-terminal amide is interesting because it suggests that peptides 
with these characteristics may have given rise to the structurally related peptides that are 
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found in asterozoan and echinozoan L-type SALMFamide precursors. Accordingly, our data 
indicate that the evolutionary origin of L-type SALMFamides with a conserved histidine 
residue at position six with respect to the C-terminal amide can be traced back to the common 
ancestor of extant echinoderms. However, it is in the Asteroidea that peptides with this 
characteristic are most prevalent and furthermore the histidine typically occupies the third 
position from the N-terminus, forming a potential Cu(II) and Ni(II) binding site. This feature 
of SALMFamides derived from the L-type SALMFamide precursor in starfish is interesting 
from an evolutionary and functional perspective and therefore, as described below, we have 
investigated if these peptides do indeed bind Cu(II) and Ni(II) ions. To do this we synthesized 
and analysed neuropeptides derived from the L-type SALMFamide precursor in the common 
European starfish A. rubens.  
 
<<INSERT FIGURE 3>> 
 
3.3 Determination of the sequence of a cDNA encoding the L-type SALMFamide 
precursor in A. rubens 
 Cloning and sequencing of a 1028 bp cDNA encoding the A. rubens L-type 
SALMFamide precursor confirmed the predicted amino acid sequence obtained from 
transcriptome sequence data. Thus, the A. rubens L-type SALMFamide precursor is a 210 
residue protein with a predicted 23-residue signal peptide and seven L-type SALMFamides 
that are bounded by dibasic cleavage sites (Fig.  S1). Four of these peptides (AYHSALPF-
NH2, AYHTGLPF-NH2, GYHSALPF-NH2 and GYHSGLPF-NH2) contain the ATCUN 
motif H2N-xxH (Fig. 1 and S1). Two other peptides (PAGASAFHSALSY-NH2 and 
LHSALPF-NH2) contain a histidine residue but it is not in the third position from the N-
terminus, whilst the peptide S1 (GFNSALMF-NH2) lacks a histidine residue altogether.  
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3.4 Electronic and circular dichroism spectroscopy highlights coordination of copper 
and nickel to L-type SALMFamides      
To investigate the copper binding ability of peptides derived from the A. rubens L-
type SALMFamide precursor, we chose three representative peptides potentially containing 
copper sites: AYHSALPF-NH2, GYHSGLPF-NH2 and LHSALPF-NH2. We initially used 
electronic spectroscopy to probe metal binding. Figure 4A shows the spectra obtained after 
titration of Cu2+ or Ni2+ into AYHSALPF-NH2. Addition of Cu2+ to AYHSALPF-NH2 gives 
rise to an absorption band centred on 520 nm and the intensity tends to stop increasing with 
copper addition at around one equivalent (Fig. 4B). An absorption maximum of 520 nm is 
indicative of Cu2+ bound with only nitrogen coordination [2]. Titration of Ni2+ generates an 
absorption band at 420 nm (Fig. 4A) and, in contrast to Cu2+, the slope of the binding curve 
changes, rather than plateauing, at one equivalent (Fig. 4B). A peak at 420 nm is suggestive 
of Ni2+ bound in a square-planar, four-coordinate geometry [34]. Both the stoichiometry and 
wavelength maxima of Cu2+ and Ni2+ binding are entirely consistent with coordination of 
these metals to an ATCUN site. As expected, titration of these metals into GYHSGLPF-NH2 
produced identical results (Fig. 4C, D). The ATCUN motif generally binds copper and nickel 
via the N-terminal nitrogen, the histidine imidazole nitrogen, and intervening amide nitrogens 
(i.e. {Na, 2N-, NIm}) and therefore the nature of the amino acid side chains is of less 
importance, especially in this case where only the presence of a glycine or alanine 
differentiates the motif in AYHSALPF-NH2 and GYHSGLPF-NH2. A feature of an ATCUN 
site is the lack of changes to the absorption maximum as a function of pH [2]. Accordingly, 
the maximum wavelength of [CuIIGYHSGLPF-NH2] (520 nm) remains constant from ~ pH 5 
(Fig. S2A). In contrast to AYHSALPF-NH2 and GYHSGLPF-NH2, titration of Cu2+ into 
LHSALPF-NH2 generates a peak at 600 nm, but, similar to the previous peptides, the 
absorbance plateaus at around one equivalent Cu2+ (Fig. 4E, F). An absorbance at 600 nm 
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suggests this peptide contains one or more oxygen ligands in its coordination sphere. A pH 
titration of this peptide shows the 600 nm wavelength maximum remains constant until 
higher pH values (> pH 9) where increasing absorption at wavelengths <600 nm suggests 
incorporation of an additional nitrogen donor (Fig. S2B) [28]. 
 
<<INSERT FIGURE 4>> 
 
  To further examine the copper binding sites we used NMR. The presence of low 
concentrations of paramagnetic Cu2+ tends to broaden peaks associated with protons lying 
within ~7Å of the metal. Addition of ~0.1 equivalent Cu2+ to GYHSGLPF-NH2 results in 
selective broadening of the C2H (7.68 ppm) and C4H (6.92 ppm) protons of the imidazole 
ring (Fig. 5A) which tends to confirm His3 is a nitrogen donor. Some broadening of peaks 
due to the His3 HE protons (~3.61 ppm, shifted downfield due to ring current effects of Tyr2) 
is also observed (see Fig. S3 for expanded regions). Coordination of copper to the His3 amide 
and imidazole nitrogen (NG) could account for the perturbation of the beta protons. 
Additionally, peaks due to Tyr2 HE protons also show some broadening consistent with 
coordination to the nearby amide of Tyr2 (Fig. 5A, Fig. S3). In a similar manner addition of 
Cu2+ to LHSALPF-NH2 results in a loss of peaks due to histidine imidazole protons (Fig. 
5B). It is difficult to assess changes to the His3 HE peaks (~ 3.15 ppm, Fig. 5B) given overlap 
with Phe8 HE. A change in both the broadness and chemical shift is readily observed for the 
Leu1 HE peaks (~1.6 ppm), and to some extent the HG peaks (~0.9 ppm) (Fig. S3B), which 
suggests coordination to the nearby amide nitrogen of the amino acid. Intriguingly, despite 
having the same ratio of copper to peptide in both GYHSGLPF-NH2 and LHSALPF-NH2 the 
His imidazole peaks in the [CuIILHSALPF-NH2] sample have completely broadened and 
disappeared, but remain to some extent in the [CuIIGYHSGLPF-NH2] sample (Fig. 5). This 
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suggests that the different copper-binding sites in these peptides have different copper on/off 
rates (on the NMR timescale) with [CuIILHSALPF-NH2] at a comparatively faster rate than 
[CuIIGYHSGLPF-NH2]. The C2H and C4H peaks observed in the slowly exchanging 
[CuIIGYHSGLPF-NH2] spectrum (Fig. 5A) presumably arise from the apo form of the 
complex.         
 
<<INSERT FIGURE 5>> 
 
We next analysed the copper-complexes by circular dichroism (CD) spectroscopy. 
CD spectroscopy is a useful tool to analyse Cu2+ complexes because the d-d transitions that 
overlap to give a single broad peak in electronic spectroscopy can often be resolved into 
positive and negative peaks in CD [35]. The CD spectrum of [CuIIGYHSGLPF-NH2] is 
shown in Figure 6A (the spectrum of [CuIIAYHSALPF-NH2] has identical bands and is not 
shown). Positive bands are apparent at 316 nm and 490 nm and a weaker negative band 
appears at 570 nm. The bands at 490 nm and 570 nm can be attributed to d-d transitions, 
whereas a band around 320 nm may be attributed to an amide nitrogen → Cu2+ charge 
transfer (CT). In line with the absorption spectroscopy, the intensity of the bands tends to 
stop increasing at one equivalent Cu2+ (Fig. 6B). The visible CD spectrum of 
[CuIIGYHSGLPF-NH2] is strikingly similar to the copper-bound peptides GGH and DAHK, 
as well as that of copper-bound full length human serum albumin, suggesting similar 
coordination in all [35, 36]. The ATCUN motif is known to have high affinity for copper (Kd 
~ 10-12 – 10-14 M) and should out-compete the weaker copper chelator glycine [37]. Titration 
of [CuIIGYHSGLPF-NH2] with glycine (up to 7× molar excess vs. copper) caused no 
apparent change to the CD spectrum of [CuIIGYHSGLPF-NH2] which tends to support 
binding via a high affinity ATCUN motif (data not shown). Further analysis of the copper 
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affinity of the SALMFamide peptides was not undertaken. The CD spectra obtained during a 
Cu2+ titration of LHSALPF-NH2 are shown in Figure 6C. The spectra have a negative peak at 
300 nm, a positive peak at 346 nm and a broad positive feature around 600 nm, and all are 
relatively low intensity and largely identical to the CD spectrum of [CuIIGHK] [36]. The peak 
at 300 nm may be attributed to an amide nitrogen → Cu2+ CT, whereas the 346 nm peak is 
likely due to an imidazole nitrogen → Cu2+ CT, which is further supported by an absence of 
this peak in copper-bound tripeptides that lack a histidine [28, 35]. 
 
<<INSERT FIGURE 6>> 
 
3.5 EPR spectroscopy predicts presence of a copper-linked ternary complex between 
GYHSGLPF-NH2 and LHSALPF-NH2.  
The X-band (~9 GHz) EPR spectra of [CuIIGYHSGLPF-NH2] and [CuIILHSALPF-
NH2], each with a Cu2+:peptide ratio of 0.96, are shown in Figure 7A and 7B respectively 
(the spectrum of [CuIIAYHSALPF-NH2] is identical to that of [CuIIGYHSGLPF-NH2] and is 
not shown) . The EPR spectra for both reveal an axially symmetric Cu(II) centre (i.e. gx   gy 
z gz). For [CuIIGYHSGLPF-NH2] nitrogen superhyperfine (shf) coupling is apparent in the 
gx, gy (perpendicular, g┴ ) region between 315 – 350 mT and analysis of the characteristic 
parallel gz and Az(63Cu) values suggests that the copper ion is in a 4-nitrogen environment 
(Table 1) at this pH (7.2) [38]. In [CuIILHSALPF-NH2], the peak at g┴ is considerably 
broadened, suggesting the presence of multiple species, however some nitrogen coupling is 
apparent. The presence of multiple species is supported by Cu(II) speciation studies with 
GHK where the presence of mono- and bis-complexes was indicated at pH values similar to 
those used here [3]. The parallel values (Table 1) of [CuIILHSALPF-NH2] are different to 
those of [CuII(GYHSGLPF-NH2)] and suggest inclusion of oxygen donors which has 
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increased gz and decreased Az relative to that observed for [CuIIGYHSGLPF-NH2]. Most 
likely the predominant [CuIILHSALPF-NH2] species contains a CuN2O2 site which previous 
work suggests has average values of gz = 2.238 – 2.265 and Az   0.0182 – 0.0187 cm-1 and is 
consistent with the electronic spectrum (Fig. 1E) [39].  When apo-GYHSGLPF-NH2 is added 
to [CuIILHSALPF-NH2] such that the peptides are equimolar (i.e. [Cu]:[total peptide] is 
~0.5:1) then the spectrum in figure 7C is obtained. In this case the spectrum was best fit with 
CuII in a rhombically distorted environment (i.e. gx z gy z gz). The gz and Az values are 
different to those of the pure copper-peptides and suggest that an additional nitrogen atom/s 
has been added to the coordination sphere [38]. Nitrogen coupling is not observed on the 
parallel components of the spectrum, however, compared to [CuIILHSALPF-NH2] the 
linewidth in the perpendicular region has narrowed and the nitrogen shf coupling is more 
apparent. To improve resolution at gx,y the spectrum was differentiated and the expanded 
region (Fig. 7c) reveals the 14N shf coupling in more detail. Theoretically, each copper 
hyperfine coupling is split into (2nI + 1) (I =1) lines, where n is the number of magnetically 
equivalent nitrogen ligands. Although it is instructive to examine the features at g┴, in reality 
the number of lines is complicated by various factors such as the presence of multiple 
species, non-equivalent nitrogens and overlap with parallel features [40]. The experimental 
[CuIILHSALPF-NH2] + apo-GYHSGLPF-NH2 spectrum (Fig. 7c, exp) was fit assuming four 
and three nitrogens and the results (Fig. 7c 4N, 3N) suggest that the most likely coordination 
involves four nitrogen ligands. In neither case are the lines on the low field (320 – 325 mT) 
side of g┴ well simulated, however on the high field side (335 – 338 mT) the four nitrogen 
simulation clearly fits the experimental spectrum more closely in both the line position and 
intensity than the three nitrogen simulation. The high field transitions are known to be 
particularly sensitive to the number of nitrogen ligands [40]. Thus, we predict that the 
predominant species formed when apo-GYHSGLPF-NH2 is added to [CuIILHSALPF-NH2] 
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has CuII in a four-nitrogen environment. The EPR spectrum does not resemble 
[CuIIGYHSGLPF-NH2] indicating that apo-GYHSGLPF-NH2 has not just abstracted all the 
copper from [CuIILHSALPF-NH2]. It is likely that the oxygen donors observed in 
[CuIILHSALPF-NH2] have been replaced by nitrogens from apo-GYHSGLPF-NH2 to form a 
copper-linked ternary complex. We predict that the histidine imidazole from GYHSGLPF-
NH2 is a nitrogen contributor the ternary complex. This result is not unprecedented, as a 
previous study showed addition of the amino acid histidine to a solution of [CuIIGHK] 
generated a 4N complex where the oxygen donor in [CuIIGHK] was displaced by a nitrogen 
from the histidine imidazole group [36]. Collection of spectra at alternative frequencies, such 
as S-band (~ 4 GHz) which avoids broadening due to g- and A-strain correlations, may allow 
nitrogen coupling to be more completely analysed.                  
We next wondered that if [CuIILHSALPF-NH2] can form 4N complexes with apo-
GYHSGLPF-NH2, then why does copper titration of LHSALPF-NH2 by UV/Vis 
spectroscopy (Fig. 4E, F) show a simple 1:1 stoichiometry with a peak at 600 nm indicative 
of N/O coordination, when the 4N mononuclear binary complex [CuII(LHSALPF-NH2)2] can 
presumably be formed? Given that NMR shows different copper on/off rates for the 
complexes then maybe the timescale of the UV/Vis experiment accounts for the observed 
result. To explore this [CuIILHSALPF-NH2] (Fig. 7D) was scanned, left at room temperature 
for 2 hours then re-scanned. The resultant spectrum (Fig. 7D) shows that the d-d transitions 
are now much broader than in the initial sample and there is increased absorption at 
wavelengths shorter than 600 nm (no evidence of aggregation was observed). Taken together 
with the EPR data, this suggests that initially a simple [CuIILHSALPF-NH2] complex with a 
2N2O donor set is formed, but over time other species such as a 4N [CuII(LHSALPF-NH2)2] 
having absorption around 500 nm also occur. Along with ternary complexes, these species 
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may also contribute to the EPR spectrum (Fig. 7c) which increases the difficulty of accurately 
simulating the nitrogen coupling.   
 
<<INSERT FIGURE 7>> 
 
4.0 Discussion 
In this study we analysed SALMFamide neuropeptide precursor sequences from 
species belong to the five extant classes of the phylum Echinodermata and established that 
peptides derived from the L-type SALMFamide precursor in starfish (class Asteroidea) were 
over represented with the N-terminal sequence H2N-xxH. This sequence is a well-known 
copper-binding site termed an ATCUN-motif and suggested that these peptides should bind 
the metal. Using a range of spectroscopic techniques we show that the L-type SALMFamides 
in the starfish species A. rubens that contain the motif (e.g. GYHSGLPF-NH2) do indeed bind 
Cu(II) as well as Ni(II) ions. Taken together, the spectroscopic evidence indicates Cu(II) 
binding to these peptides involves the His3 imidazole nitrogen, the N-terminal nitrogen and 
intervening amide nitrogen atoms. Ni(II) binds in a similar manner resulting in a square-
planar diamagnetic complex. In addition, we show that LHSALPF-NH2, a heptapeptide 
derived from the A. rubens L-type SALMFamide precursor, can also bind copper but instead 
of four nitrogen atoms as ligands the complex initially includes oxygen atoms. Displacement 
of the oxygen ligand/s in the presence of GYHSGLPF-NH2 resulted in the formation of a 
copper-linked ternary complex (a heterodimer). To the best of our knowledge, this is the first 
study to report the identification of a neuropeptide precursor that contains multiple Cu(II)-
binding neuropeptides.  
 Comparative analysis of the sequences of SALMFamide precursors in echinoderms 
has provided a basis for investigation of the evolutionary history of the histidine residue that 
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confers on starfish L-type precursor-derived SALMFamides the ability to bind Cu(II) ions. 
Crinoids, which occupy a basal position in echinoderm phylogeny, appear to have only a 
single SALMFamide precursor, unlike asterozoans (starfish, brittlestars) and echinozoans 
(sea urchins, sea cucumbers), which have an L-type and F-type SALMFamide precursor (Fig. 
8). The crinoid SALMFamide precursor contains a core of twelve peptides that include F-
type-like SALMFamides. However, at both the N- and C-terminal extremities of the 
precursor there are single L-type SALMFamides that have a histidine residue in the sixth 
position from the C-terminus, in common with the majority of SALMFamides derived from 
L-type precursors in asterozoans and echinozoans. We postulate, therefore, that following 
duplication of a SALMFamide precursor gene in a common ancestor of the Asterozoa and 
Echinozoa, one copy retained the L-type peptides with a histidine residue at position six with 
respect to the C-terminal amide, lost other peptides and then gave rise to the L-type 
SALMFamide precursors that occur in extant asterozoans and echinozoans. Conversely, the 
other copy retained the core peptides that do not have conserved histidine residues, lost the L-
type peptides with a histidine residue at position six with respect to the C-terminal amide and 
then gave rise to the F-type SALMFamide precursors that occur in extant asterozoans and 
echinozoans. In surveying the occurrence in echinoderms of L-type SALMFamides with a 
histidine residue at position six with respect to the C-terminal amide, it is striking that in 
starfish (Asteroidea) these peptides are most abundant and have acquired the ATCUN motif 
by virtue of the histidine occupying the third position from the N-terminus (Fig. 8).  
 
<<INSERT FIGURE 8>> 
 
The concentration of free copper ions in seawater is estimated in the range of 10-11 – 
10-13 M, whilst the total dissolved copper concentration, which includes organically 
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complexed copper, is ~ 10-8 M [41-43]. It is likely that the copper content of the extracellular 
milieu in starfish is similar to that of seawater because these animals, like other marine 
invertebrates, are osmoconformers. Therefore, upon release from neurons L-type 
SALMFamides are likely to encounter copper ions at concentrations near the Kd established 
for ACTUN motif-containing peptides (10-12 – 10-14 M [37]) and therefore will compete for 
copper ions, even when taking into consideration the ligands present in seawater which can 
have high binding constants [42]. Interestingly, the SALMFamides, like other amidated 
neuropeptides, traffic through the Golgi network where they are C-terminally amidated by the 
copper-metalloenzyme peptidyl-glycine alpha-amidating monooxygenase [44]. The trans-
Golgi contains copper because several proteins are loaded with copper in this cellular 
compartment during their biosynthesis. Although copper is pumped into the trans-Golgi as 
Cu+ by the Menkes ATPase [45], it is not clear whether it stays as Cu+ or if there is some 
oxidation to Cu2+. It is therefore interesting to speculate that, rather than being metallated 
after release, L-type SALMFamides containing an ATCUN motif may in fact have copper 
already bound to them prior to release from starfish neurons. 
At the molecular level, how may the presence of bound Cu(II) ions affect the 
bioactivity of L-type SALMFamides? Our previous studies on the prototypical 
SALMFamides S1 and S2, L-type SALMFamides that do not bind metal, indicate that their 
bioactivity is primarily determined by the C-terminal region of the peptides. The N-terminal 
tetrapeptide of S2 (SGPY) does, however, influence peptide structure by causing S2 to self-
associate at high concentrations and form highly-structured multimers [15]. We predicted that 
S2’s structure and activity may change as it diffuses away from sites of release and becomes 
less concentrated. Further, addition of the SGPY tetrapeptide to the N-terminus of S1 confers 
structure on this chimeric peptide that is not observed with the S1 peptide. Now we show that 
the L-type SALMFamide precursor-derived peptide LHSALPF-NH2 can form a copper-
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linked ternary complex (a heterodimer) with GYHSGLPF-NH2, and the chemistry suggests 
that LHSALPF-NH2 will form similar ternary complexes with any of the ATCUN-containing 
L-type SALMFamides. The formation of these copper complexes (monomers and dimers) 
may modify receptor binding or make the peptides more resistant to proteolysis. Interestingly, 
evidence that copper binding affects enzymatic degradation of neuropeptides has been 
reported recently. Herman et al. [46] reported that human gonadotropin-releasing hormone 
(GnRH), which has a histidine residue at position two, binds Cu2+ ions and this confers on 
GnRH increased resistance to enzymatic degradation in extracts of hypothalamic and 
pituitary tissue. Accordingly, the copper-linked ternary complexes of LHSALPF-NH2 and 
ACTUN motif-containing L-type SALMFamides may likewise be more resistant to 
enzymatic degradation than the monomeric peptides in the absence of copper.  
At the physiological level, previous studies have revealed that SALMFamide 
neuropeptides S1 and S2 cause dose-dependent relaxation of the starfish cardiac stomach in 
vitro and trigger cardiac stomach eversion in vivo (Melarange et al., 1999). This 
pharmacological effect of SALMFamides is of interest because starfish feed by everting their 
cardiac stomach over prey and partially digesting prey tissue externally. Therefore, it is 
proposed that SALMFamides may mediate neural control of cardiac stomach eversion during 
starfish feeding behaviour [12]. Furthermore, extraoral feeding is unique to starfish (Class 
Asteroidea) amongst extant echinoderms [47]. We speculate, therefore, that the acquisition 
and proliferation of L-type SALMFamides that have an ATCUN motif and bind copper ions 
in starfish may be associated with a role in regulating stomach eversion. For example, the 
secretion of proteases by cells in the mucosal epithelium of the cardiac stomach during 
feeding creates a proteolytic environment [47], which may have favoured acquisition of 
structural characteristics that protect SALMFamides from aminopeptidases. Therefore, in this 
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context, our findings may provide a basis for experimental studies in which the physiological 
significance of copper-binding neuropeptides could be further investigated. 
  
  
27 
 
Acknowledgements 
 
This work was supported by a Leverhulme Trust grant (RPG-2013-351) awarded to MRE  
and National Science Foundation (USA) grant awards DEB 1036416, 1036358, 1036366, and 
1036368. We thank Ben Grupe, Alex Kerr, Brian Livingstone, Allison Miller, Jim Nestler, 
Greg Rouse and Nerida Wilson for collecting some of the specimens used for transcriptome 
sequencing. CEJ acknowledges the significant contribution Prof. Graeme Hanson gave to the 
international bioinorganic community and to EPR spectroscopy. He will be missed. 
 
  
28 
 
References 
 
1. Taghert, P.H. and M.N. Nitabach, Peptide neuromodulation in invertebrate model 
systems. Neuron, 76 (2012): pp. 82-97.DOI: 10.1016/j.neuron.2012.08.035. 
2. Harford, C. and B. Sarkar, Amino terminal Cu(II)- and Ni(II)-binding (ATCUN) 
motif of proteins and peptides: metal binding, dna cleavage, and other 
properties. Acc. Chem. Res., 30 (1997): pp. 123-130.DOI: 10.1021/ar9501535. 
3. Conato, C., H. Kozlowski, P. Mlynarz, F. Pulidori, and M. Remelli, Copper and 
nickel complex-formation equilibria with Lys-Gly-His-Lys, a fragment of the 
matricellular protein SPARC. Polyhedron, 21 (2002): pp. 1469-1474.DOI: Pii 
S0277-5387(02)00952-X. 
4. Harford, C. and B. Sarkar, Neuromedin C binds Cu(II) and Ni(II) via the ATCUN 
motif: implications for the CNS and cancer growth. Biochem. Biophys. Res. 
Commun., 209 (1995): pp. 877-82.DOI: 10.1006/bbrc.1995.1580. 
5. Russino, D., E. McDonald, L. Hejazi, G.R. Hanson, and C.E. Jones, The tachykinin 
peptide neurokinin B binds copper forming an unusual [CuII(NKB)2] complex 
and inhibits copper uptake into 1321N1 astrocytoma cells. ACS Chem. Neurosci., 
4 (2013): pp. 1371-81.DOI: 10.1021/cn4000988. 
6. Kowalik-Jankowska, T., E. Jankowska, Z. Szewczuk, and F. Kasprzykowski, 
Coordination abilities of neurokinin A and its derivative and products of metal-
catalyzed oxidation. J. Inorg. Biochem., 104 (2010): pp. 831-42.DOI: 
10.1016/j.jinorgbio.2010.03.016. 
7. Pietruszka, M., E. Jankowska, T. Kowalik-Jankowska, Z. Szewczuk, and M. 
Smuzynska, Complexation abilities of neuropeptide gamma toward copper(II) 
ions and products of metal-catalyzed oxidation. Inorg. Chem., 50 (2011): pp. 7489-
99. DOI: 10.1021/ic2002942. 
8. Elphick, M.R., SALMFamide salmagundi: The biology of a neuropeptide family 
in echinoderms. Gen. Comp. Endocrinol., 205 (2014): pp. 23-35.  
DOI 10.1016/j.ygcen.2014.02.012. 
9. Elphick, M.R., D.A. Price, T.D. Lee, and M.C. Thorndyke, The SALMFamides: a 
new family of neuropeptides isolated from an echinoderm. Proc. Bio.l Sci., 243 
(1991): pp. 121-7.DOI: 10.1098/rspb.1991.0020. 
10. Elphick, M.R., J.R. Reeve, Jr., R.D. Burke, and M.C. Thorndyke, Isolation of the 
neuropeptide SALMFamide-1 from starfish using a new antiserum. Peptides, 12 
(1991): pp. 455-9.DOI: 10.1016/0196-9781(91)90083-2. 
11. Ohtani, M., E. Iwakoshi, Y. Muneoka, H. Minakata, and K. Nomoto, Isolation and 
characterization of bioactive peptides from the sea cucumber, Stichopus 
japonicus. Peptide Science - Present and Future,  (1999): pp. 419-420.DOI: 
10.1007/0-306-46864-6_137. 
12. Elphick, M.R. and R. Melarange, Neural control of muscle relaxation in 
echinoderms. J. Exp. Biol., 204 (2001): pp. 875-85. 
13. Melarange, R., D.J. Potton, M.C. Thorndyke, and M.R. Elphick, SALMFamide 
neuropeptides cause relaxation and eversion of the cardiac stomach in starfish. 
Proc. Biol. Sci., 266 (1999): pp. 1785-1789.DOI: 10.1098/rspb.1999.0847. 
14. Melarange, R. and M.R. Elphick, Comparative analysis of nitric oxide and 
SALMFamide neuropeptides as general muscle relaxants in starfish. J. Exp. 
Biol., 206 (2003): pp. 893-9. DOI: 10.1242/jeb.00197. 
15. Otara, C.B., C.E. Jones, N.D. Younan, J.H. Viles, and M.R. Elphick, Structural 
analysis of the starfish SALMFamide neuropeptides S1 and S2: the N-terminal 
29 
 
region of S2 facilitates self-association. Biochim. Biophys. Acta., 1844 (2014): pp. 
358-65.DOI: 10.1016/j.bbapap.2013.10.013. 
16. Jones, C.E., C.B. Otara, N.D. Younan, J.H. Viles, and M.R. Elphick, Bioactivity and 
structural properties of chimeric analogs of the starfish SALMFamide 
neuropeptides S1 and S2. Biochim. Biophys. Acta., 1844 (2014): pp. 1842-50.DOI: 
10.1016/j.bbapap.2014.08.001. 
17. Elphick, M.R., D.C. Semmens, L.M. Blowes, J. Levine, C.J. Lowe, M.I. Arnone, and 
M.S. Clark, Reconstructing SALMFamide Neuropeptide Precursor Evolution in 
the Phylum Echinodermata: Ophiuroid and Crinoid Sequence Data Provide New 
Insights. Front. Endocrinol. (Lausanne), 6 (2015): pp. 2. DOI: 
10.3389/fendo.2015.00002. 
18. Elphick, M.R., S. Achhala, and N. Martynyuk, The evolution and diversity of 
SALMFamide neuropeptides. PLoS One, 8 (2013): pp. e59076.DOI: 
10.1371/journal.pone.0059076. 
19. Bather, F.A., The Echinodermata, in A treatise on zoology, part III, A and C., R.R. 
Lankester, Editor. 1900, Black: London. 
20. Mooi, R. and B. David, What a new model of skeletal homologies tells us about 
asteroid evolution. American Zoologist, 40 (2000): pp. 326-339.DOI: Doi 
10.1668/0003-1569(2000)040[0326:Wanmos]2.0.Co;2. 
21. Janies, D. and R. Mooi, Xyloplax is an asteroid., in Echinoderm Research, M. Candia 
Carnevali and F. Bonasoro, Editors. 1998, Balkema: Rotterdam. p. 311-316. 
22. Janies, D., Phylogenetic relationships of extant echinoderm classes. Canadian 
Journal of Zoology-Revue Canadienne De Zoologie, 79 (2001): pp. 1232-1250.DOI: 
DOI 10.1139/cjz-79-7-1232. 
23. Telford, M.J., C.J. Lowe, C.B. Cameron, O. Ortega-Martinez, J. Aronowicz, P. 
Oliveri, and R.R. Copley, Phylogenomic analysis of echinoderm class relationships 
supports Asterozoa. Proc. Biol. Sci., 281 (2014).DOI: Doi 10.1098/Rspb.2014.0479. 
24. O'Hara, T.D., A.F. Hugall, B. Thuy, and A. Moussalli, Phylogenomic Resolution of 
the Class Ophiuroidea Unlocks a Global Microfossil Record. Curr. Biol., 24 
(2014): pp. 1874-1879.DOI: DOI 10.1016/j.cub.2014.06.060. 
25. Reich, A., C. Dunn, K. Akasaka, and G. Wessel, Phylogenomic Analyses of 
Echinodermata Support the Sister Groups of Asterozoa and Echinozoa. Plos 
One, 10 (2015).DOI: DOI 10.1371/journal.pone.0119627. 
26. Cannon, J.T., K.M. Kocot, D.S. Waits, D.A. Weese, B.J. Swalla, S.R. Santos, and 
K.M. Halanych, Phylogenomic Resolution of the Hemichordate and Echinoderm 
Clade. Curr. Biol., 24 (2014): pp. 2827-2832.DOI: DOI 10.1016/j.cub.2014.10.016. 
27. Yun, S.S., M.C. Thorndyke, and M.R. Elphick, Identification of novel 
SALMFamide neuropeptides in the starfish Marthasterias glacialis. Comp. 
Biochem. Physiol. A Mol. Integr. Physiol., 147 (2007): pp. 536-42. 
28. Conato, C., R. Gavioli, R. Guerrini, H. Kozlowski, P. Mlynarz, C. Pasti, F. Pulidori, 
and M. Remelli, Copper complexes of glycyl-histidyl-lysine and two of its 
synthetic analogues: chemical behaviour and biological activity. Biochim. 
Biophys. Acta., 1526 (2001): pp. 199-210.DOI: 10.1016/S0304-4165(01)00127-1. 
29. Semmens, D.C., R.E. Dane, M.R. Pancholi, S.E. Slade, J.H. Scrivens, and M.R. 
Elphick, Discovery of a novel neurophysin-associated neuropeptide that triggers 
cardiac stomach contraction and retraction in starfish. J. Exp. Biol., 216 (2013): 
pp. 4047-53.DOI: 10.1242/jeb.092171. 
30. Haas, B.J., A. Papanicolaou, M. Yassour, M. Grabherr, P.D. Blood, J. Bowden, M.B. 
Couger, D. Eccles, B. Li, M. Lieber, M.D. MacManes, M. Ott, J. Orvis, N. Pochet, F. 
Strozzi, N. Weeks, R. Westerman, T. William, C.N. Dewey, R. Henschel, R.D. 
30 
 
Leduc, N. Friedman, and A. Regev, De novo transcript sequence reconstruction 
from RNA-seq using the Trinity platform for reference generation and analysis. 
Nature Protocols, 8 (2013): pp. 1494-1512.DOI: DOI 10.1038/nprot.2013.084. 
31. Stoll, S. and A. Schweiger, EasySpin, a comprehensive software package for 
spectral simulation and analysis in EPR. J. Magn. Reson., 178 (2006): pp. 42-
55.DOI: 10.1016/j.jmr.2005.08.013. 
32. Froncisz, W. and J.S. Hyde, Broadening by strains of lines in the g-parallel region 
of Cu2+ EPR spectra. J. Chem. Phys., 73 (1980 ): pp. 3123 - 3131.DOI: 
10.1063/1.440548. 
33. Marat, K., SpinWorks 4.1.0. 2014, University of Manitoba: Canada. 
34. Lever, A.B.P., Inorganic Electronic Spectroscopy. 1984, New York: Elsevier. 
35. Stanyon, H.F., X. Cong, Y. Chen, N. Shahidullah, G. Rossetti, J. Dreyer, G. 
Papamokos, P. Carloni, and J.H. Viles, Developing predictive rules for 
coordination geometry from visible circular dichroism of copper(II) and 
nickel(II) ions in histidine and amide main-chain complexes. FEBS J., 281 (2014): 
pp. 3945-54.DOI: 10.1111/febs.12934. 
36. Hureau, C., H. Eury, R. Guillot, C. Bijani, S. Sayen, P.L. Solari, E. Guillon, P. Faller, 
and P. Dorlet, X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK 
complexes: influence on their redox properties. Chemistry, 17 (2011): pp. 10151-
60.DOI: 10.1002/chem.201100751. 
37. Trapaidze, A., C. Hureau, W. Bal, M. Winterhalter, and P. Faller, Thermodynamic 
study of Cu2+ binding to the DAHK and GHK peptides by isothermal titration 
calorimetry (ITC) with the weaker competitor glycine. J. Biol. Inorg. Chem., 17 
(2012): pp. 37-47.DOI: 10.1007/s00775-011-0824-5. 
38. Peisach, J. and W.E. Blumberg, Structural implications derived from the analysis 
of electron paramagnetic resonance spectra of natural and artificial copper 
proteins. Arch. Biochem. Biophys., 165 (1974): pp. 691-708.DOI: 10.1016/0003-
9861(74)90298-7. 
39. Bonomo, R.P., V. Cucinotta, A. Giuffrida, G. Impellizzeri, A. Magri, G. Pappalardo, 
E. Rizzarelli, A.M. Santoro, G. Tabbi, and L.I. Vagliasindi, A re-investigation of 
copper coordination in the octa-repeats region of the prion protein. Dalton Trans.,  
(2005): pp. 150-8.DOI: 10.1039/b415727c. 
40. Hyde, J.S., B. Bennett, E.D. Walter, G.L. Millhauser, J.W. Sidabras, and W.E. 
Antholine, EPR of Cu2+ prion protein constructs at 2 GHz using the 
g(perpendicular) region to characterize nitrogen ligation. Biophys. J., 96 (2009): 
pp. 3354-62.DOI: 10.1016/j.bpj.2009.01.034. 
41. Michael, J.P. and G. Pettenden, Marine metabolites and metal ion chelation: The 
facts and the fantasies. Angew. Chem. Int. Ed. Engl., 32 (1993): pp. 1-23. 
42. Kogut, M.B. and B.M. Voelker, Strong copper-binding behavior of terrestrial 
humic substances in seawater. Environ. Sci. Technol., 35 (2001): pp. 1149-56.DOI: 
10.1021/es0014584. 
43. Ndungu, K., Model predictions of copper speciation in coastal water compared to 
measurements by analytical voltammetry. Environ. Sci. Technol., 46 (2012): pp. 
7644-52.DOI: 10.1021/es301017x. 
44. Satani, M., K. Takahashi, H. Sakamoto, S. Harada, Y. Kaida, and M. Noguchi, 
Expression and characterization of human bifunctional peptidylglycine alpha-
amidating monooxygenase. Protein Expr. Purif., 28 (2003): pp. 293-302.DOI: 
10.1016/S1046-5928(02)00684-8. 
31 
 
45. Harrison, M.D., C.E. Jones, M. Solioz, and C.T. Dameron, Intracellular copper 
routing: the role of copper chaperones. Trends Biochem. Sci., 25 (2000): pp. 29-
32.DOI: DOI:10.1016/S0968-0004(99)01492-9. 
46. Herman, A., H. Kozlowski, M. Czauderna, K. Kochman, K. Kulon, and A. Gajewska, 
Gondaoliberin (GnRH) and its copper complex (Cu-GnRH) enzymatic 
degradation in hypothalmic and pituitary tissue in vitro. J. Physiol. Pharmacol, 63 
(2012): pp. 69-75. 
47. Ruppert, E.E., R.S. Fox, and R.D. Barnes, Invertebrate Zoology: A Functional 
Evolutionary Approach. 7th ed. 2003, Belmont, CA: Brooks Cole Thompson. 
 
  
32 
 
Figure Legends 
 
Figure 1. C-terminally aligned sequences of SALMFamide neuropeptides derived from L-
type SALMFamide precursors in the Asteroidea (Patiria miniata, Asterias rubens and 
Remaster gourdoni) [1], Ophiuroidea (Ophionotus victoriae, Ophioderma brevispinum and 
Ophiothrix angulata [2], Echinoidea (Strongylocentrotus purpuratus, Arbacia punctulata and 
Eucidaris tribuloides) [3] and Holothuroidea (Apostichopus japonicus, Psolus spp and 
Pannychia moseleyi) [4]. The third amino acid residue from the C-terminal amide has been 
highlighted in red if it is leucine or isoleucine, yellow if phenylalanine or tyrosine and grey if 
any other residue. Histidine residues located in the sixth position from C-terminal amide have 
been highlighted in turquoise.  
Figure 2. C-terminally aligned sequences of SALMFamide neuropeptides derived from from 
F-type SALMFamide precursors in the Asteroidea (Patiria miniata, Asterias rubens and 
Remaster gourdoni) [1], Ophiuroidea (Ophionotus victoriae, Astrophyton muricatum and 
Ophiothrix angulata [2], Echinoidea (Strongylocentrotus purpuratus, Arbacia punctulata and 
Lytechinus variegatus) [3] and Holothuroidea (Apostichopus japonicus, Psolus spp and 
Stichopus chloronatus) [4]. The third amino acid residue from the C-terminal amide has been 
highlighted in red if it is leucine or isoleucine, yellow if phenylalanine or tyrosine and grey if 
any other. Histidine residues located in the sixth position from C-terminal amide have been 
highlighted in turquoise. 
Figure 3. SALMFamide neuropeptides derived from SALMFamide precursors in the 
Crinoidea (Antedon mediterranea, Isometra vivipara and Oligometra serripinna). The third 
amino acid residue from the C-terminal amide has been highlighted in red if it is leucine or 
isoleucine, yellow if phenylalanine or tyrosine and grey if any other residue. Histidine located 
in the sixth position from C-terminal amide residues have been highlighted in turquoise. 
Figure 4. Copper(II) and nickel(II) titrations monitored by electronic spectroscopy.  
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(A) Titration of Cu2+ (solid black line) into AYHSALPF-NH2 (100 PM, 10 mM nEM, pH 
7.44) results in the formation of a peak at 520 nm. Titration of Ni2+ (dashed red line) results 
in an increase in absorption at 420 nm. (B) Plots of the absorbance at 520 nm (Cu2+) and 420 
nm (Ni2+) as a function of added metal. Both curves plateau around 100 PM metal, 
suggesting 1:1 stoichiometry. (C) Titration of Cu2+ (solid black line) and Ni2+ (dashed red 
line) into GYHSGLPF-NH2 (80 PM, 10 mM nEM, pH 7.44) results in the formation of peaks 
at 520 nm and 420 nm, respectively. (D) Plots of the absorbance at 520 nm (Cu2+) and 420 
nm (Ni2+) as a function of added metal. Both curves plateau around 80 PM metal, suggesting 
1:1 stoichiometry. (E) Titration of Cu2+ into LHSALPF-NH2 (110 PM, 10 mM nEM, pH 
7.44) generates an absorption band at 600 nm and the binding curve (F) suggests a 
stoichiometry of 1:1.   
Figure 5.  Paramagnetic copper causes broadening of GYHSGLPF-NH2 and LHSALPF-NH2 
1H NMR spectra. (A) 1H NMR spectra of ~500 PM apo-GYHSGLPF- NH2 in 10% D2O/90% 
H2O, pH 7.2 (bottom trace) and after the addition of 0.1 equivalent Cu2+ (top trace). 
Assignment of selected perturbed peaks is shown in top trace. (B). 1H NMR spectra of ~500 
PM apo-LHSALPF- NH2 in 10% D2O/90% H2O, pH 7.2 (bottom trace) and after the addition 
of 0.1 equivalent Cu2+ (top trace). Assignment of selected perturbed peaks is shown in top 
trace. Expansion of assigned peaks in both A and B are shown in supplementary material 
figure S3. 
Figure 6. Copper(II) titrations monitored by circular dichroism spectroscopy. (A) CD spectra 
(300 – 700 nm) were collected as Cu2+ was titrated into apo-GYHSGLPF-NH2 (93 PM, 10 
mM nEM, pH 7.7). Peaks at 490 nm and 570 nm are due to d-d transitions and the peak in the 
near-UV (316 nm) can be attributed to an amide N-→ Cu(II) CT. (B) The intensity of the 
peaks at 316 nm (■) and 490 nm (x) plotted as a function of [Cu(II)]/[GYHSGLPF-NH2] 
plateaus at a ratio near one. (C) CD spectra obtained during a titration of apo-LHSALPF-NH2 
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(96 PM, 10 mM nEM, pH 7.7) with Cu2+ show low intensity peaks at 300 nm (amide N→ 
Cu(II) CT), 346 nm (imidazole N→ Cu2+ CT)  and 600 nm (d-d transition). (D) The intensity 
of the peaks at 300 nm (■) and 346 nm (x) plotted as a function of [Cu(II)]/[LHSALPF-NH2] 
plateaus at a ratio near one.   
Figure 7. X-band EPR spectra of CuII-bound peptides. (A) First derivative spectrum of 
[CuII(GYHSGLPF-NH2)] (Q = 9.433547, 262 PM, 10 mM nEM, pH 7.2, 0.98 equivalents 
Cu2+), dashed line is simulated spectrum, (B) first derivative spectrum of [CuII(LHSALPF-
NH2)] (Q = 9.433526, 1 mM, 10 mM nEM, pH 7.2, 0.96 equivalents Cu2+), (C) first 
derivative spectrum of a mixture of [CuII(LHSALPF-NH2)] (Q = 9.432792, 260 PM, 10 mM 
nEM, pH 7.2) and apo-GYHSGLPF-NH2 (243 PM,10 mM nEM, pH 7.2). Inset (c) shows the 
second derivative spectrum of (C) highlighting the perpendicular region (exp), along with the 
same region after simulation assuming four (4N) or three (3N) nitrogen donors. (D) Titration 
of Cu2+ into LHSALPF-NH2 (110 PM, 10 mM nEM, pH 7.44) generates an absorption band 
at 600 nm. Leaving the sample at room temperature for 2 hrs generated a spectrum with 
broadened d-d transitions.  
Figure 8. The occurrence and properties of SALMFamide precursors in species representing 
each of the five extant echinoderm classes. A. rub is the starfish Asterias rubens (Asteroidea), 
O. vic is the brittlestar Ophionotus victoriae (Ophiuroidea), S. pur is the sea urchin 
Strongylocentrotus purpuratus (Echinoidea), A. jap is the sea cucumber Apostichopus 
japonicus (Holothuroidea) and A. med is the feather star Antedon mediterranea (Crinoidea). 
Signal peptides are shown in blue, spacer peptides are in white, monobasic or dibasic 
cleavage sites are in green, SALMFamides with a C-terminal FXXamide motif are in yellow, 
a LXXamide motif are in red and a XXXamide motif are in grey. In addition, SALMFamides 
containing a histidine residue at the sixth position from the C-terminal amide are marked with 
H and peptides in which this histidine residue forms an ATCUN motif have been marked 
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with an asterisk. The data indicate that the common ancestor of all extant echinoderms had a 
single SALMFamide precursor, including histidine-containing L-type SALMFamides, as in 
extant crinoids. Then duplication (x2) of the SALMFamide precursor in the common ancestor 
of extant Eleutherozoa followed by divergence gave rise to two types of precursor: the L-type 
precursor, which typically includes SALMFamides with a conserved histidine residue, and 
the F-type precursor. Figure modified from Elphick et al. [17]. 
 
 
 
Table 1. Spin Hamiltonian parameters for CuIISALMFamide peptides. 
 
Complex gx gy gz Ax (63Cu)a  Ay (63Cu)a  Az (63Cu)a  
[CuII(GYHSGLPF-NH2)] 2.044 2.044 2.176 22.1 22.1 200.9 
[CuII(LHSALPF-NH2)] 2.042 2.042 2.220 - - 187.5 
[CuII(LHSALPF-NH2) + 
apoGYHSGLPF-NH2 
2.045 2.067 2.207 11.5 12.1 197.3 
a. units 10-4 cm-1 
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P. miniata 
PAGSPVFHSALTYa 
AFHSALPFa 
GLHSALPFa 
GFNSALMFa 
IHTALPFa 
GYHSALPFa 
GYHTGLPFa 
A. rubens 
PAGASAFHSALSYa 
AYHSALPFa 
AYHTGLPFa 
GFNSALMFa 
LHSALPFa 
GYHSALPFa 
GYHSGLPFa 
R. gourdoni 
Absent 
 AAYHSGLPFa  
AYHSAMPFa 
GYNSALMFa 
MHSALPFa 
 GYHSGLPFa  
 SFHSGLPFa  
O. victoriae 
SGRRNPSLNSGLIFa 
SRLPFHSGLMQa 
SRPQFHTGFMMa 
KAGQRLRFSDGMLFa 
O. brevispinum 
THSLNSGLLFa 
NKLPFHSGLMQa 
TRPVFHSGFLMa 
KAGARLRWSDGMLFa 
O. angulata 
SGRSRTYLNSGLLFa 
SKLPFHSALMQa 
GKQKAKFHSAMLLa 
KGSRLRWSNGMAFa 
S. purpuratus  
NMGSIHSHSGIHFa 
MRLHPGLLFa 
A. punctulata  
SRGIYKNSGINFa 
MRYHKGISFa 
E. tribuloides 
SRGIYKNSGINFa 
MRYHKGISFa 
A. japonicus 
VVSRAWSPLVGQTGIAFa 
TRSRSMFGNTALPFa 
MGFTGNTGILLa 
Psolus spp 
GMRSRWNPLVGQSGLSLa 
TRSRSSFFGHSALSYa 
GGIRGFSGNSAILMa 
P. moseleyi 
TARRWSPLVGQTGIAFa 
TRSRAMFGHSALAFa 
MGFTGNTGILLa 
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P. miniata 
DVSDRQREIDLAAQQPFYPYa 
TDVPGRPSGFVFa 
SNGPYSMSGLRSLTFa 
ADLFRSYAFa 
ALGSNFAFa 
GYSSFDFa 
AGLGSSFTFa 
ALGSSFSFa 
SGLSSFTFa 
A. rubens 
pQQSDREREVEAAQTQFYPYa 
TDPRKASGGFTFa 
SGPYSFNSGLTFa 
NIFGSYDFa 
AYGNNFSFa 
GMGVSSFSFa 
Absent 
AFGDFSFa 
NNGLSSFTFa 
R. gourdoni 
NNNDRQLEMDMAAARAQQPFYPYa 
TDVPGRPSGFVFa  
GRLSGLGSLSFa 
Absent 
ALGSNFAFa 
GYAGLSSFNFa 
AGLGSSFAFa 
ALGSSFTFa  
GNSLSSFAFa  
O. victoriae 
pQAVRPGGGAPMNVPVKMSGFSFa 
Absent 
SAGATPSKLAGFAFa 
GAMDAFAFa 
 PSGDPMSAFSFa 
 NPMNSLSALAFa 
 AGMDPNSLNAFNFa 
 DPLSAFSFa 
 GMDSLSAFNFa 
 GRDHLSAFSFa 
 GRNPMNGLSAFDFa 
 GGMDAFAFa 
 GYENGLSGYAFa 
A. muricatum 
pQAGNRPSSGVPMKVPAKMSGFAFa  
SAKAAAGSAKMSGFAFa  
 SASAGSKPVKLAGFAFa  
 GAMQAFTFa  
 LSSDPAGLSAFSFa 
 YPVSLSALTFa 
 GMNPSGISAFNFa 
 DPFSTFSFa 
 GMESSGLSAFNFa 
 GYDQSGLSAFSFa 
 WPTNSLSAFDFa 
 GMNAFTFa 
Absent 
O. angulata 
pQAATPRSGGSGLPMNVPVKMSGFAFa  
Absent 
 SAKSGGDKPVKLAGFAFa 
 AAMDAFTFa 
Absent 
 DPTGLSALTFa 
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 RMDPLSAFSFa 
 AMDPAGLSAFSFa 
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GLSSFAFa 
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L. variegatus 
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PPITTRSKFTWa 
DAFSSFSFa 
GMSPFSFa 
SMPSFAFa 
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PHGGSAFIFa 
GNVAFSFa 
A. japonicus 
GVPPYVVKVTYa 
FKSPFMFa 
 GYSPFMFa 
 ARYSPFTFa 
 GGYSALYFa 
 VPELAESDGGQSKLYFa 
 GHRGGQFSQFKFa 
FKSSFYLa 
Psolus spp 
EGIPPNLMKLSYa 
Absent 
AYSKFMFa 
ANYSPLMFa 
AYSRFFFa 
Absent 
AIPGKYSKFMFa 
Absent 
S. chloronatus 
GVPPTMLKLSYa 
FQNPFYFa 
GYSPFMFa 
GYSPLIFa 
AGYSALYFa 
Absent 
GHYSKFIFa 
Absent 
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A. mediterranea 
ANTSSEPINNWIRALPVLHRGLYFa 
NPALSEFMLa 
DPSFSSYMLa 
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 EARLSDYIMa 
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I. vivipara 
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O. serripinna 
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1    ctcgagagtagctacttgacacatacacactgcgtaacactcgggtcgcaagctacttct 
61   ttgctcgctggccgtagacaactctttgatatctctcgaccaccatcaaaaacgcagaca 
121  caacacaatttcgcgtggtttatttaaacgcacacgaggggcctacctgccttgggtttt 
181  ttccgggtgtttaattttgtgtactcaccgtcccaaatgaagggccaacaccttctagcc 
                                          M  K  G  Q  H  L  L  A    8  
241  gtagcagtggttgtcgtcgccggttcgtttggaatcatcgaggcgtactctccatttggg 
      V  A  V  V  V  V  A  G  S  F  G  I  I  E  A  Y  S  P  F  G   28  
301  ggctataaccgagcaccttttgacaatgtttgggtgcgagcggacagcatggctcgtgga 
      G  Y  N  R  A  P  F  D  N  V  W  V  R  A  D  S  M  A  R  G   48  
361  ggctcgacgggggaggacgaagccaacgaacagcgaatgacgggagccaagcgaccggct 
      G  S  T  G  E  D  E  A  N  E  Q  R  M  T  G  A  K  R  P  A   68  
421  ggtgcctcagcgttccactccgctctgtcgtacggcaaacgaggcgacgatgacagcgcc 
      G  A  S  A  F  H  S  A  L  S  Y  G  K  R  G  D  D  D  S  A   88  
481  gaagtggagcgccgagcctaccactcggccctgcccttcggcaagagaacacccatcgag 
      E  V  E  R  R  A  Y  H  S  A  L  P  F  G  K  R  T  P  I  E  108  
541  aaacgcgcctaccacacaggtctccccttcggaaagagggacgacgaagccgccgaacaa 
      K  R  A  Y  H  T  G  L  P  F  G  K  R  D  D  E  A  A  E  Q  128  
601  gacgccatgatggagaggcgtggcttcaactcggccctgatgttcggtaaacgactacac 
      D  A  M  M  E  R  R  G  F  N  S  A  L  M  F  G  K  R  L  H  148  
661  agtgctctaccgttcggtaagcgcggctaccacagtgctctgccgttcgggaagagattg 
      S  A  L  P  F  G  K  R  G  Y  H  S  A  L  P  F  G  K  R  L  168  
721  gataccactgatgaaggagatatcatcgagagaagaggttaccatagcgggctaccgttc 
      D  T  T  D  E  G  D  I  I  E  R  R  G  Y  H  S  G  L  P  F  188  
781  ggcaagcgcgctactgacgatgaagccgttaatgacatactagaccaattaagaagcgaa 
      G  K  R  A  T  D  D  E  A  V  N  D  I  L  D  Q  L  R  S  E  208  
841  gagaattgacttttataaagaactgtaatccttaaaaatcagcttatatactaatctaac 
      E  N  *                                                     210 
901  agtgcttaggatacgacaatatcggttggtgatcagtttagttaccttacaaaaccctct 
961  ctcaactagtcatatcaaccttagcgaggacaacgcgggttacacaatgtttcgcatact 
1021 taaaaaaa 
 
 
Figure S1: Asterias rubens L-type SALMFamide precursor. The DNA sequence of 
a transcript (lowercase, 1028 bases) encoding an L-type SALMFamide precursor 
protein (uppercase, 210 amino acid residues). The sequence data was first determined 
by manual assembly of four overlapping contig sequences (1073975, 192719, 104468 
and 1057915) and then cDNA sequencing was employed to confirm the section of the 
DNA sequence bounded by the PCR primer sequences (bold, underline). Bases in the 
sequenced cDNA that differ from the assembled transcript sequence are shown in 
underlined italics. The predicted signal peptide of the precursor protein is shown in 
blue and the seven putative SALMFamide peptides are shown in red, with C-terminal 
glycine residues that are likely substrates for amidation shown in orange. Putative 
dibasic cleavage sites (KR, RR) are shown in green and the asterisk shows the 
position of the stop codon.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. pH titration of [CuII(GYHSGLPF-NH2)] and [CuII(LHSALPF-NH2)]. (A). 
[CuIIGHYSGLPF-NH2] (93.3 PM) was prepared in H2O at an initial pH of 4.1. The pH was 
increased by the addition of small aliquots of NaOH and the visible electronic spectra 
obtained at pH values of 4.9, 6.5 and 8.3. (B). [CuIILHSALPF-NH2] (100 PM) was prepared 
in H2O at an initial pH of 3.8. The pH was incrementally increased via addition of NaOH and 
the visible electronic spectra obtained at pH values of 4.16, 5.38, 7.02 and 8.39. Spectra were 
collected using a Perkin Elmer U-3100 spectrometer and a 10 mm pathlength cuvette. 
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Figure S3. Copper titration of [CuII(GYHSGLPF-NH2)] and [CuII(LHSALPF-NH2)]. 
(A) 1H NMR spectra of ~500 mM apo-GYHSGLPF- NH2 in 10% D2O/90% H2O, pH 7.2 
(bottom trace) and after the addition of 0.1 equivalent Cu2+ (top trace). Assignment of 
selected perturbed peaks is shown in top trace. (B). 1H NMR spectra of ~500 mM apo-
LHSALPF- NH2 in 10% D2O/90% H2O, pH 7.2 (bottom trace) and after the addition of 0.1 
equivalent Cu2+ (top trace). Assignment of selected perturbed peaks is shown in top trace.  
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